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ABSTRACT
Recombination is a powerful weapon in the evolutionary arsenal of retroviruses such
as HIV. It enables the production of chimeric variants or recombinants that may confer
a selective advantage to the pathogen over the host immune response. Recombinants
further accentuate differences in virulence, disease progression and drug resistance muta-
tion patterns already observed in non-recombinant variants of HIV. This thesis describes
the development of a rapid genotyper for HIV sequences employing supervised learning
algorithms and its application to complex HIV recombinant data, the application of a
hierarchical model for detection of recombination hotspots in the HIV-1 genome and the
extension of this model enabling estimation of the association between recombination
probabilities and covariates of interest.
The rapid genotyper for HIV-1 explores a solution to the genotyping problem in the
machine learning paradigm. Of the algorithms tested, the genotyper built using Bayesian
additive regression trees (BART) was most successful in efficiently classifying complex
recombinants that pose a challenge to other currently available genotyping methods. We
also developed a novel method, bootSMOTE, for generating synthetic data in order to
supplement insufficient training data. We found that supplementation with synthetic
recombinants especially boosts identification of complex recombinants. We describe the
genotyper software available for download as well as a web interface enabling rapid
classification of HIV-1 sequences.
Hotspots for recombination in the HIV-1 genome are modeled using spatially smoothed
changepoint processes. This hierarchical model uses a phylogenetic recombination de-
xii
tection model of dual changepoint processes at the lower level. The upper level applies
a Gaussian Markov random field (GMRF) hyperprior to population-level recombina-
tion probabilities in order to efficiently combine the information from many individual
recombination events as inferred at the lower level. Focusing on 544 unique recombi-
nant sequences, we found a novel hotspot in the pol gene of HIV-1 while confirming the
presence of high recombination activity in the env gene.
Valuable insights into the molecular mechanism of recombination may be gained by
extending the GMRF model to include covariates of interest. We add a level to the hi-
erarchical model and allow for the simultaneous inference of recombination probabilities
as well their association with genomic covariates of interest. Using a set of 527 unique
recombinants, we confirmed the presence of the pol hotspot. Interestingly, we found sig-
nificant positive associations of spatial fluctuations in recombination probabilities with
genomic regions prone to forming secondary structure as well as significant negative
associations with regions that support tight RNA-DNA hybrid formation. Overall, our
results support the theory that pause sites along the genome promote recombination.
1CHAPTER 1. GENERAL INTRODUCTION
1.1 Introduction
The persistence of the Human Immunodeficiency Virus (HIV) as a major pathogen
causing a global pandemic bears testimony to the success of the molecular mechanisms
promoting its rapid evolution (Burke, 1997). HIV is a lentivirus that can stay apparently
dormant in the host for many years after infection (Vogt, 1997). Eventually, it leads to
the Acquired Immunodeficiency Syndrome, characterized by an attenuated host immune
system. The infected individual becomes increasingly susceptible to a multitude of
opportunistic infections that prove fatal (Weiss, 1993; Douek et al., 2009).
HIV packages its genetic material in the form of two single stranded positive sense
RNA molecules deposited in the host cell upon infection (Coffin, 1979). The reverse
transcription stage in its replication cycle is responsible for creating a double stranded
DNA copy using a packaged RNA molecule as template. Integration of viral DNA with
the host genome enables it to use host resources for production of HIV proteins (Temin,
1991). The reverse transcription machinery introduces 3×10−5 mutations per nucleotide
per cycle of replication (Levy et al., 2004) in the 108−109 virions produced per day. Such
high rates of replication and mutation together with the recombinogenic nature of the
replication complex contribute to the rich genetic diversity of the virus (Robertson et al.,
1995). Recombination in HIV refers to a mechanism wherein the reverse transcription
complex is prone to switching between the two viral RNA templates present in the host
cell. This leads to chimeric or recombinant DNA molecules that are mosaics of the two
2RNA molecules packaged by the infecting virion (Negroni and Buc, 2001). Inter-subtype
recombination occurs when the two RNA templates used are genetically distinct. As of
2010, nearly 50 stable genetically distinct variants or genotypes of HIV-1 have been
identified (HIV-Database, 2010). Of these, 11 are non-recombinant and referred to as
subtypes while the rest are inter-subtype recombinants known as Circulating Recombi-
nant Forms (CRFs) (McCutchan, 2006). Also present are “transient” recombinants or
Unique Recombinant Forms (URFs) believed to be products of isolated recombination
events. Genotypes display marked differences in virulence, disease progression, preferred
mode of transmission, drug resistance mutation profiles as well as sensitivity to detection
assays (Spira et al., 2003; Madani et al., 2004; Baeten et al., 2006; Swanson et al., 2005;
Colson et al., 2007).
Identifying a recombinant, its parental genotypes and the location of the recombina-
tion breakpoints, is therefore, not only essential from the perspective of efficient clinical
management (Geretti, 2006) but is also imperative towards better understanding of
the recombination mechanism. Galetto et al. (2006) point out that in order to under-
stand the mechanism of recombination, it is important to ascertain causes or triggers
that promote template switching by the replication complex. Further, experimental and
computational analyses (Dykes et al., 2004; Balakrishnan et al., 2003; Magiorkinis et al.,
2003; Fan et al., 2007; Galli. et al., 2008) have shown that the location of recombination
breakpoints is not random along the genome. This suggests that some regions of the
genome, by virtue of sequence, structural or functional features, favor recombination.
Many genotyping techniques exist (McGuire et al., 1997; Husmeier and Wright, 2001;
Rozanov et al., 2004; de Oliveira et al., 2005; Wu et al., 2007). Most are distance
or phylogeny based and use a sliding window technique (Grassly and Holmes, 1997;
Husmeier and Wright, 2001; Husmeier and McGuire, 2003). In most cases, the strategy
is to use a reference set of known genotypes and compare a query sequence with it
using some measure of relatedness. Such methods are able to predict the occurrence
3of recombination and the parental genotypes. However, in recent years there has been
a rise in the number of recombinant sequences (HIV-Database, 2010). Most existing
genotyping methods find the task of genotyping complex recombinant sequences very
challenging (Holguin et al., 2008a). As the viral genome gets more and more complex,
simple relatedness matrices prove insufficient in providing information useful for accurate
genotyping. A more sophisticated approach is to use these matrices to look for patterns
that might appear to be peculiar to a genotype. Supervised learning algorithms provide
the apt paradigm for such exploration. The first part of this thesis presents a novel
application of supervised learning algorithms to rapid genotyping of HIV-1 sequences.
While genotypers can identify parental genotypes, they lack the ability to accu-
rately identify the position of recombination breakpoints in the genome. Suchard et al.
(2002) provided a Bayesian framework for inference of recombination breakpoint lo-
cations. Minin et al. (2005) and Fang et al. (2007) developed this model further by
de-convoluting other nuisance parameters from the parameters of interest: the num-
ber and locations of recombination breakpoints. Being able to accurately estimate the
recombination breakpoints puts us in the advantageous position of being able to com-
bine this information from many sequences and gain insight into the spatial variation of
recombination probabilities in the HIV genome. To achieve this, Minin et al. (2007) de-
scribe a hierarchical model that places a spatially smoothing Gaussian Markov Random
Field (GMRF) prior on the recombination probabilities in order to effectively combine
information from analyses of individual sequences. We developed this model further to
enhance its ability to deal with more diverse datasets. Further, we extended the model
to be able to simultaneously infer the association of the recombination probabilities with
covariates. This extension provides, for the first time, a unified framework to establish
a relationship between recombination probabilities and genomic features that may be
associated with recombination.
41.2 Thesis Organization
This thesis is presented as a series of manuscripts and is organized as follows. Back-
ground material is presented in two review chapters. Chapter 2 reviews HIV biology
and machine learning algorithms while Chapter 5 reviews statistical techniques used in
the development of models in later chapters.
Chapter 3 describes the application of supervised learning algorithms to the problem
of rapidly genotyping HIV-1 sequences. We build a classifier using a setup of paral-
lel binary classifiers, one for each genotype in the HIV reference set. Relatedness of
a sequence to the reference sequences is summarized using various metrics producing
feature sets that form suitable input for the binary classifiers. Next we describe a novel
method to produce synthetic sequences suitable for data supplementation, bootSMOTE.
Finally, the chapter provides details of the genotyper software and its web interface. This
manuscript was prepared by authors Misha L. Rajaram (MLR) and Karin S. Dorman
(KSD) who also jointly conceptualized and designed the study. MLR implemented the
classifier and performed the experiments. Yves Sucaet implemented the web interface.
Chapter 4 presents methods for careful curation of large HIV datasets. It also shows
results from the application of the model described by Minin et al. (2007) to large
datasets. Authors Vladimir N. Minin (VNM), Marc A. Suchard and KSD were respon-
sible for conceptualizing the study. MLR and KSD designed the study and prepared the
manuscript. MLR implemented the clustering algorithm and obtained results presented
herein.
Chapter 6 presents the extension of the hierarchical model to include covariate in-
ference. We present results of application of the model to a dataset of HIV sequences
to infer the spatial preference for recombination probabilities as well as their associa-
tion with some genomic covariates. Authors KSD and VNM initially conceived of the
extension model, which was later greatly adapted by KSD and MLR. MLR and KSD de-
5signed the experiments and prepared the manuscript. MLR implemented the model and
conducted experiments. Susan Carpenter and Drena Dobbs were involved in long dis-
cussions about this work, and in particular suggested the secondary structure covariates
to include in the model and guided interpretation of results.
Chapter 7 presents an alternate hierarchical GMRF model specially suited to deal
with binomial responses. This model doubles the speed of inference while providing
variance stabilized data. Finally, Chapter 8 presents general conclusions and plans for
future work.
6CHAPTER 2. REVIEW I
2.1 The Human Immunodeficiency Virus (HIV)




Species: Human Immunodeficiency Virus
The Human Immunodeficiency Virus (HIV), is a lentivirus belonging to family Retroviri-
dae. Retroviruses are RNA viruses that replicate via the reverse transcriptase enzyme
when it creates DNA copies from their RNA genome. Enzyme integrase then facilitates
the integration of viralDNAwith the host genome. Thereafter, the viral DNA uses the
host machinery for replication. Lentiviruses are characterized by long incubation periods
wherein the integrated viral DNA lies clinically dormant (Desport, 2010).
HIV infects cells vital to the human immune response, namely, CD4+ T helper cells,
macrophages and dendritic cells. The infection progresses in three main stages. The
first or primary infection stage, occurs 2 − 4 weeks post-exposure and is marked by a
sharp drop in numbers of circulating CD4+ cells. Most infected individuals at this stage
develop influenza-like viremia caused upon activation of CD8+ T cells that kill infected
cells (Kahn and Walker, 1998). The second stage is asymptomatic and can last between
two weeks and 20 years. At this stage, the virus is found predominantly in immune
cells and lymph nodes. Infected individuals, while capable of passing on the infection,
7display no clinical symptoms. The third stage is characterized by a rapid decline in
CD4+ cell count leading to the emergence of symptoms related to mild opportunistic
infections. The final stage, known as the Acquired Immunodeficiency Syndrome (AIDS)
results from loss of cell mediated immunity due to very low CD4+ cell counts (≤ 200
cells/µl). Such extensive damage to the host immune system results in increasingly
severe opportunistic infections that eventually prove fatal (WHO, 2007).
As of 2006, 0.6% of the world’s population was infected with HIV and since its dis-
covery the infection is estimated to have claimed 25 million lives (UNAIDS, 2006). HIV
is transmitted through infected blood, semen, vaginal fluid and breast milk. The main
modes of transmission include unsafe sex with infected individuals, use of contaminated
needles, through breast milk and from an infected mother to her child at birth (Kilmarx,
2008). Antiretroviral therapy serves to delay the onset of AIDS in infected individuals
and is known to prevent the transmission from mother to child. However, the virus is
also accumulating resistance mutations to these drugs often rendering them ineffective.
2.1.1 Structure and Genome Organization of HIV
The HIV virion is spherical and ∼ 120 nm in diameter. At the core the p24 viral
proteins form a conical capsid. The capsid encloses two positive sense single stranded
RNA molecules found tightly bound with nucleocapsid proteins p6 and p7 as well as the
reverse transcriptase and integrase enzymes. The nucleocapsid proteins serve to protect
the RNA from digestion by nucleases. Also present in the capsid are other enzymes and
proteins such as protease, vif, rev and nef required at various stages of viral replication.
Surrounding the capsid is a matrix formed of p17 protein particles. The matrix is
responsible for the integrity of the virion. Covering the matrix, is the envelope, formed
when the capsid buds out of the host cell. The function of the envelope is to ensure
attachment to a host cell. Towards this, the envelope has several spike-like structures
made of viral glycoprotein particles, gp120 and gp41. gp120 or SU is present on the
8surface and gp41 or TM , a trans-membrane glycoprotein serves to anchor the surface
protein and are in turn held in place by the matrix proteins (Kuiken et al., 2010).
Fig. 2.1 shows the linear genome organization of the virus. The HIV genome is
∼ 9.7 kb long and comprised of three main retroviral genes gag, pol and env which
contain all the structural information required to produce new viral particles. The
gag (group specific antigen) gene codes for the capsid and matrix proteins. The gene
product is a fusion protein p55 that is later cleaved by the protease enzyme to form
p17, p24, p6 and p7. The pol gene codes for the enzymes required in the viral life
cycle. The reverse transcriptase (RT) enzyme, an RNA dependent DNA polymerase, is
responsible for producing double stranded cDNA copies of the viral RNA. Integrase is
required for integration of the viral DNA with the host DNA and protease is required for
processing viral gene products to make them suitable for packaging and assembly of new
virions. The gag and pol genes are adjacent on the genome and include a small overlap
region. The 55 kDa gag precursor protein is produced by conventional translation. At a
rate 20-fold lower, a programmed -1 frameshift during translation produces the gag-pol
polyprotein. The polyprotein is then cleaved to form the assembly proteins and the
enzymes (Hill et al., 2005).
The third major gene, env codes for a glycoprotein gp160 that gives rise, upon
cleavage, to the envelope proteins gp120 and gp41. There are six other genes in the
HIV genome that have regulatory or accessory functions. The tat or transactivator
gene is responsible for promoting transcription of the virus. The first 59 nucleotides
of the HIV genome contain the transactivator activation region or “TAR”. Binding of
the tat gene product to the TAR element serves to accelerate transcription of the viral
genome integrated with the host DNA. The rev gene is responsible for nuclear export
of viral mRNA. It binds to the rev responsive element or RRE on the intact mRNA
and transports it out of the nucleus. Nef or negative replication factor is a negative
regulator of replication. Vif or viral infectivity factor is believed to increase infectivity
9of the virion. Its gene product binds to host APOBEC3G that is aimed at rendering the
virion non-productive. The vpr or viral protein R is responsible for nuclear localization
of the pre-integration complex that consists of the viral RNA, reverse transcriptase and
the integrase enzymes. The final regulatory gene is vpu in HIV-1 and vpx in HIV-2.
vpu is believed to be involved in assembly and packaging of new viral particles while vpx
seems to have functions similar to vpr (Kuiken et al., 2010).
2.1.2 HIV Replication
Fig. 2.2 shows a simplified version of the life cycle of the virus in a host cells. The in-
fective cycle of the virus starts with attachment of the virion via the gp120 surface glyco-
protein to host cells presenting the CD4+ antigen receptors on their surface. This mainly
includes two types of human immune cells– CD4+ T lymphocytes and macrophages.
Chemokine receptors present on host cells, CCR5 and CXCR4, act as co-receptors that
strengthen the attachment of the virion (Chan and Kim, 1998; Wyatt and Sodroski,
1998). Attachment prompts fusion of the viral envelope to the cell membrane of the
host cell, releasing the contents of the viral capsid into the host cytoplasm (Coffin et al.,
1997).
The next step is the reverse transcription of the RNA genome by reverse transcrip-
tase. The replication machinery also degrades the RNA template as it moves along,
making the DNA copy. Next a complementary DNA strand is added to form a double
stranded DNA copy of the viral genome. This double stranded DNA is then inserted
in the host DNA with the help of the integrase enzyme. At this stage this integrated
viral genome is referred to as the provirus. Upon suitable activation, the host repli-
cation machinery starts making RNA copies of the viral DNA. These are transported
to the cytoplasm and corresponding protein products produced. The protease enzyme
cleaves these products to produce proteins that are then packaged and assembled into
new virions. Virions are released from the host cell through budding (Coffin et al., 1997).
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2.2 Genetic Diversity of HIV
The combination of a fast replication cycle and lack of a proof reading mechanism in
the replication machinery affords the virus a great evolutionary advantage as evidenced
by its rich genetic diversity. The replication cycle of the virus is very fast, producing
between 108 and 109 virions per day (Robertson et al., 1995; Rambaut et al., 2004). The
reverse transcription produces replicates with a high mutation rates of over 3×10−5 per
nucleotide per replication cycle (Levy et al., 2004). HIV has two main types: HIV-1
that is responsible for the current pandemic and HIV-2 that is known to cause infections
restricted to parts of West Africa. Compared to HIV-1, HIV-2 shows slower disease
progression and is often not as infective as HIV-1 (MacNeil et al., 2007).
HIV-1 is further divided into three groups: M (Major) causing over 90% of all HIV
infections, N (Non-major) and O (Other) that are also found isolated in Africa (Robert-
son et al., 2000). In 2009, an isolate closely related to gorilla Simian Immunodeficiency
virus was found in a Cameroonian woman and designated as HIV -1 Group P (Plantier
et al., 2009). Further, group M has 11 genetically distinct subtypes, A-D, F-H, J-K with
subtypes A and F divided into subtypes A1/A2 and F1/F2 (Robertson et al., 2000).
The inter-subtype genetic diversity can be as high as 30% in the env gene and about
15% in the gag gene (Spira et al., 2003). Fig. 2.3 shows the global distribution of HIV
subtypes. Note that they tend to be geographically isolated except in Africa which has
a substantial representation of all subtypes.
2.2.1 Recombination in HIV
The genetic diversity of HIV is further augmented by the recombinogenic properties of
the replication machinery. Co-infected or super-infected host cells are prone to produce
virions that co-package genetically distinct genotypes (Smith et al., 2005; Chohan et al.,
2005; Piantadosi et al., 2007). Upon infection by such a heterozygous virion, there is a
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high likelihood of the production of recombinants during reverse transcription.
Mechanism of recombination: Several competing hypotheses exist on the mech-
anism of recombination. Of these, the most popular is the “copy choice” model (Coffin,
1979) that postulates that recombination occurs when the reverse transcription ma-
chinery switches templates midway during the production of the minus strand cDNA
resulting in a mosaic genome that has fragments from both RNA molecules co-packaged
by the infecting virion. Fig 2.4 illustrates the copy choice model for recombination.
Further, most recombination events seem to occur during minus strand synthesis (An-
derson et al., 1998; Zhang et al., 2000). Variations to the “copy choice” model serve
to incorporate factors that influence various stages of the process such as the reverse
transcriptase activity (Chen et al., 2003; DeStefano et al., 1996; Diaz and DeStefano,
1996; Roda et al., 2002a; Wu et al., 1995), secondary structure formation (Andersen
et al., 2003; Balakrishnan et al., 2001, 2003; Moumen et al., 2001; Negroni and Buc,
2000) and viral nucleocapsid proteins (Negroni and Buc, 1999; Roda et al., 2003).
Pausing and recombination rates: The presence of pause sites along the genome
has been implicated as one of the major factors affecting recombination rates. Homopoly-
meric G and C stretches as well as secondary structures have been shown to cause pausing
of the reverse transcription machinery (Klarmann et al., 1993; Suo and Johnson, 1997;
Wu et al., 1995). In vitro studies show that such pause sites are positively associated
with strand transfer events (Roda et al., 2002a, 2003; Zhuang et al., 2002). Lanciault
and Champoux (2006) reported that unpaired nucleotides were associated with lowered
recombination rates in vitro. Similar conclusions were made by Dykes et al. (2004) for
crossover points in the gag gene.
Types of recombinants: The spread of the AIDS pandemic has also seen the rise,
in recent years, of recombinant forms that have spread through a population and caused
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local epidemics. Such inter-subtype recombinants are termed as Circulating Recombi-
nant Forms (CRFs) and currently, there are 47 identified types (HIV-Database, 2010).
A recombinant is termed a CRF if three or more epidemiologically unrelated individuals
are found infected by it. All other inter-subtype recombinants are referred to as Unique
Recombinant Forms (URFs).
2.2.2 Implications of Genetic Diversity
Genetic diversity of the virus in the form of subtypes as well as emerging recombinant
forms confers the virus with a great selective advantage over the host immune response.
Local epidemics caused by recombinants are found to be spreading (Tovanabutra et al.,
2004; Ramirez et al., 2008) with some evidence of recombinant infections taking over pure
subtype infections (Spira et al., 2003). Buonaguro et al. (2007) showed that about 18%
of infections worldwide were caused by recombinant forms. More recently, new URFs
subtypes B, C and D have been characterized in north India (Bano et al., 2009), and
there is evidence of widespread infection by CRF35 AD in Afghanistan (Sanders-Buell
et al., 2010). As many as 10 new CRFs have been identified in the past two years (Kuiken
et al., 2010). The genetic diversity in the virus manifests as phenotypic diversity in mode
of transmission, co-receptor usage, disease progression, virulence, replicative fitness and
drug resistance (Spira et al., 2003).
Cell tropism and Co-receptor preference: CCR5 and CXCR4 are chemokine
receptors present on the host cell surface that act as co-receptors to the infecting virion.
Viruses that prefer the CCR5 co-receptor are designated R5 viruses, those that prefer
CXCR4 co-receptor are grouped as X4 viruses and those that use both are called R5X4
viruses (Clapham and McKnight, 2001). Early in vitro experiments performed using
blood lymphocytes and T-cell lines confirmed that some isolates preferred to infect
macrophages (M-tropic) while others preferred CD4+ T cells as hosts (T-tropic). A
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third kind that could infect both was designated to be dual or D-tropic (Bagnarelli
et al., 2004). These experiments, along with the discovery of a high correlation between
CXCR4 use and T-tropism lead to the long-held belief that co-receptor usage is explained
completely by cell tropism with M-tropic viruses showing R5 preference and T-tropic
isolates showing X4 preference (Collman et al., 1989; Gendelman et al., 1988).
However, many studies have found that in vivo, T-cells and macrophages express
both types of co-receptors on their surface. While the majority preference for primary
infection is the CCR5 co-receptor, CD4+ T cells expressing CCR5 may also be infected
by R5 viruses. Further, studies have also shown that X4 viruses may just as efficiently use
macrophage X4 for infection, making them T-tropic or D-tropic (reviewed in Goodenow
and Collman (2006)).
Most studies involving co-receptor usage have been performed using subtypes B and
C. A majority of subtype B isolates start out as R5 populations. After years of chronic
infection, about 50% subtype B isolates are believed to favor CXCR4 usage (Bratt
et al., 1998; Peeters et al., 1999) while this proportion is lower (0-30%) in subtype C
isolates (Ping et al., 1999). Dominant X4 populations were found in CRF 01AE sam-
ples (Tscherning et al., 1998; Yu et al., 1995) and another found X4 use more common
during primary infection with subtype D than subtype A (Kaleebu et al., 2002). Esb-
jornsson et al. (2010) also found high X4 preference in CRF 02AG isolates.
R5 viruses are associated with a more stable infection with co-receptor switch oc-
curring in later stages of the disease. X4 viruses on the other hand are associated with
rapid CD4+ T cell count decline and disease progression (Philpott, 2003). Interestingly,
association of mode of transmission with co-receptor usage has also been documented
with R5 viruses believed to be predominant during sexual trasmission (Zhu et al., 1996)
Mode of transmission: While differences have been found in preference of mode
of transmission by specific genotypes, much contradictory knowledge exists on the sub-
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ject. Studies showed that in pregnant women in Kenya infected with subtypes A, C and
D, infections from subtype C were found to be more advanced than A and D (Soto-
Ramirez et al., 1996; Baeten et al., 2006). Another Kenyan study showed that subtype
C had 6.1 times higher transmission potential from infected mother to unborn child
than subtype D (Neilson et al., 1999). Later studies on the same population, however,
found no significant difference (Blackard et al., 2001). Incidence of multiple infections
and hence recombinants has been found to be high in Injection Drug Users (Templeton
et al., 2009).
Testing and Diagnosis: Most tests developed for detection of the virus in a host
system were developed in the western world and tailor-made to identify subtype B
infections accurately. As early as the 1990s, HIV-1 group O tested negative with assays
using subtype B epitopes (Gaschen et al., 2002). Much progress has been made with
many second and third generations tests that are able to identify all subtypes as well
as identify early phase and late phase antibodies (Iweala, 2004). However, these do not
have 100% sensitivity and results vary in the detection of non-B subtypes (Holguin et al.,
2008a).
Anti-retroviral drug therapy: Current drug therapy is aimed at interfering with
the viral replication cycle at various stages. Reverse transcriptase inhibitors and Pro-
tease inhibitors are among the most common therapies and were, like diagnostic tests,
developed in the western world. In patients with and without subtype B infections,
the effect of these drugs and the development of drug resistant mutations is a cause for
concern. It is interesting to note that even before the selective pressure placed by drug
treatment, subtypes display different mutation profiles (Quinones-Mateu et al., 2002;
Vergne et al., 2000). Further, in response to drug treatment, they show evolution of
clade-specific drug resistance mutations (Kinomoto et al., 2005; Spira et al., 2003).
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It is now clear that equitable clinical management of patients presenting infections
from different subtypes and/or CRFs may be of little value and therapy has to move to-
wards genotype specific treatment regimes (Butler et al., 2007; Korber and Gnanakaran,
2009).
2.3 Genotyping HIV
To achieve effective clinical management of patients infected with HIV, it is imper-
ative to be able to identify the infecting genotype successfully. The gold standard in
genotyping has been phylogenetic analysis (Arens, 1999). However, these methods rely
heavily on the choice of model and sequences used to construct the tree. Lack of experi-
ence in making these choices and in the interpretation of the resultant tree can therefore,
easily lead to misguided classification. Over the past six years, some effort has been made
to provide solutions to this problem that rely little on user expertise. The NCBI Viral
genotyping tool (Rozanov et al., 2004) uses a reference database. A query sequence is
then divided into overlapping windows and “BLAST”-ed against this database to pro-
duce a set of similarity scores. Visualized as a series of colored overlapping regions, the
ancestry of the query may be assigned by the most similar reference sequence in that
region. While a non-recombinant sequence is expected to present a monochromal sim-
ilarity plot, recombinants will likely show blocks of colors separated approximately by
the recombination breakpoints in the query. The Recombination Identification Program
(RIP) (Gifford et al., 2006) uses a similar concept using a reference set to build a matrix
of Hamming distances for overlapping windows of the query sequence. Once again, the
reference sequence closest to the query in each window is designated as parent. Earlier,
the STAR method (Gale et al., 2004) used a similar technique for sequences in the pol
region.
The REGA genotyping tool (de Oliveira et al., 2005) genotypes a test sequence by
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first using a fixed reference set to build a phylogenetic tree. It then uses measures of
proximity of the query to a reference on the tree to genotype it based on a fixed binary
decision tree. Wu et al. (2007) proposed a method of representing sequences as complete
composition vectors (CCV) that capture the nucleotide makeup of a sequence based on
observed and expected frequencies of oligomers. NCBI and RIP tools require further
phylogenetic confirmation (Rozanov et al., 2004; Gifford et al., 2006) and “human”
decisions to analyze the plots produced and genotype test sequences. CCV struggles
with accurate genotyping of CRFs (Wu et al., 2007). Several independent studies have
shown much disagreement among these methods (Gifford et al., 2006) and particular
difficulties in identifying non-B subtypes and recombinant forms (Holguin et al., 2008b).
2.4 Machine Learning Algorithms
While there is high genetic diversity in HIV sequences, the above methods obviously
suffer from not getting enough or the best information from this diversity to make
accurate classifications. Our goal is to find a platform that can use simple summary
data such as distances between sequences to discern latent patterns specific to sub-groups
of the sequences, i.e. genotypes and use these to classify newer, more complex query
sequences. Machine learning algorithms fit the paradigm of classification of complex
data very well.
Specifically, we focus on supervised learning algorithms. The general setup of such
algorithms involves the representation of the data we wish to classify, in the form of
features. Using an example from above, the distance matrix of a query sequence against
a reference set of sequences may be treated as a feature set. To achieve efficient classi-
fication, we require a Training Set. This is a dataset containing features for a set of
queries for which the true classification is known. We provide the algorithm with this set
and the list of true classifications. The algorithm then “learns” from this set, mapping
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specific patterns to specific classification groups. It is then able to use features from a
query sequence of unknown classification to look for known patterns from its “learning”
step. Upon finding one such pattern, it successfully classifies the query.
Many algorithms have been proposed to optimize the learning and classification steps.
Some popular ones do so by means of classification trees. A classification tree is a binary
tree that poses a question at each internal node. The response to this question is binary
and results in a query being sent down the left or right subtree. Ultimately, each query
lands in one of the leaves of the tree, each of which represent a class. Algorithms vary
on how they choose the splitting rules, i.e. questions in the internal nodes. Advanced
algorithms use many trees instead of just one and differ in the way they summarize the
classification from all the trees they grow.
2.4.1 Classification and Regression Trees (CART)
This is one of the earliest supervised learning algorithms (Breiman et al., 1984). As
described above, it builds one binary tree from the training set. Split rules are chosen to
best divide the data such as “Is value of column j in the feature set > x ?” where x is
some split value. Based on a binary response to this rule, each entity in the training/test
set is assigned to the left subtree or right subtree. Recursively applied, this algorithm
results in every entity traversing the tree and ending up uniquely in one of the many
leaf nodes of the tree. Leaf nodes assign final classification/predicted regression values
to member entities.
2.4.2 Random Forests
Many advance methods have been proposed since the introduction of CART. One
such that applies a popular method called bagging to the CART method is that of
Random Forests (RF)(Breiman, 2001). Bagging or Bootstrap aggregating results when
m bootstrap samples are obtained for a given training set. For each of these samples
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a classification/regression tree is grown. Final classification is the mode of the m trees
in the case of classification and their average predicted value in case of regression. This
method can thus be looked at as a special case of model averaging, also known as
ensemble techniques. However, this method has been found to overfit some datasets,
with noisy data accentuating the problem.
2.4.3 Bayesian Additive Regression Trees (BART)
BART is a technique that combines ensemble techniques with the idea of boosting.
Boosting algorithms work on the premise that a set of weak learners can produce a
single strong learner. BART is based on a sum-of-trees model (Chipman et al., 2008)
which obtains the predicted response or classification as a sum over m regression trees
fit to a user provided feature set. Chipman et al. (2008) and Zhang and Hardle (2008)
provide details of modifications that may be made to use the method for a classification
paradigm. Suitable priors placed on the depth of trees insure that they remain weak,
thus preventing over-fitting of the data.
2.4.4 Na¨ıve Bayes algorithm
Methods exist that do not use the tree structure such as the popular Na¨ıve Bayes
algorithm (Domingos and Pazzani, 1997). It is based on a probability model that as-
sumes independence of entities in the input feature set X. The likelihood of the query





where n corresponds to the number of columns in the feature set Xj. Priors and feature
probability distributions are obtained from the training set. Classification models apply
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Figure 2.2 Major events in the replication cycle of HIV. (a) Free virus at-
taches to cell surface CD4 receptor and one of the co-receptors
(CXCR4 or CCR5). (b) Fusion occurs upon successful attach-
ment. (c) HIV RNA along with proteins necessary for repli-
cation, deposited in host cytoplasm. (d) Reverse transcription
leads to generation of double stranded HIV DNA. (e) Integration
of HIV DNA with host DNA. The virus is referred to as provirus
at this stage and may lie dormant for many years before repli-
cating. (f) Host transcription machinery produces HIV mRNA
that is transported back to the cytoplasm. (g) Host translation
machinery is used to produce HIV specific protein coded by HIV
mRNA. (h) Viral proteins are packaged to form a new virion that
buds off of the cell membrane of the host cell. (i) New virion is




Figure 2.3 Global spread of HIV-1
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Figure 2.4 (a) Simultaneous infection of a single host cell with virions con-
taining genetically distinct genomic material may lead to co–
packaging of different genotypes within progeny virions. (b) In-
fection of a host cell with a virion co-packaging RNA genomes
from distinct genotypes may lead to recombination. (i) HIV
RNA is deposited in host cell following attachment and fusion
of virion with host cell.(ii) Reverse transcription occurs using
one of the two genomes as template. (iii) Transcription ma-
chinery “jumps” to the other genetically-distinct genome. (iv)
Reverse transcription continues using the acceptor RNA as tem-
plate. (v) Resultant double stranded HIV DNA is a mosaic of
the two templates. Further replication takes place as described
in Fig. 2.2 with the recombinant DNA.
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CHAPTER 3. RAPID GENOTYPING OF HIV-1 USING
SUPERVISED LEARNING ALGORITHMS
A paper to be submitted to Bioinformatics
Misha L. Rajaram, Yves Sucaet, Karin S. Dorman
Abstract
Motivation: The emergence of complex recombinant forms of HIV-1 and their docu-
mented fitness advantages over existing non-recombinant subtypes make it important
to be able to efficiently genotype them. Existing methods do very well with non-
recombinant types but face challenges with recombinant forms. Vast amounts of data
are, however, available and may be used to advantage in order to achieve efficient geno-
typing.
Results: We present the application of supervised learning algorithms to the problem
of genotyping. Sequences are represented either by a vector of oligomer frequencies or
by measuring closeness to a reference sequence in an alignment using various measures.
We demonstrate the method on a dataset of 500 sequences achieving respectively accu-
rate classification. We also present a novel method, bootSMOTE, to generate synthetic
sequences that may be used to supplement real data in cases of insufficient availability.




The Human Immunodeficiency Virus Type 1 (HIV-1) is currently believed to respon-
sible for over 90% of global HIV infections (Kuiken et al., 2010). It is represented by 11
primary non-recombinant subtypes– A1, A2, B, C, D, F1, F2, G, H, J and K. Addition-
ally there are 43 established recombinant subtypes known as Circulating Recombinant
Forms (CRFs) and countless Unique Recombinant Forms (URFs) (McCutchan, 2006).
Recombination occurs in retroviruses like HIV when the replication machinery switches
templates from one of the packaged genomes to another. The resultant recombinant
genome is a mosaic of the two originally packaged parental genomes. When the two
packaged genomes belong to different genotypes this process results in the formation of
inter-subtype recombinants (Negroni and Buc, 2001). Points on the recombinant genome
across which the genome composition changes are known as recombination breakpoints.
CRFs are inter-subtype recombinants found in three or more unrelated individuals show-
ing the same recombination profile, i.e. breakpoints at similar locations and the same
order of parental subtypes across breakpoints. Factors such as recombination, a high
mutation rate as well as the complete absence of exonuclease proof reading contribute
heavily to the genetic diversity of the virus (Spira et al., 2003).
CRFs, having triggered many local epidemics (Frange et al., 2008), now account for
about 18% of the global epidemic (Buonaguro et al., 2007) and may gradually outnumber
the pure subtypes in the global infecting pool (Tovanabutra et al., 2004; Toni et al., 2005;
Njai et al., 2006; Wang et al., 2007). Subtypes and CRFs differ in virulence (Baeten et al.,
2006), drug resistance (Spira et al., 2003; Madani et al., 2004) and sensitivity to detection
assays (Swanson et al., 2005; Colson et al., 2007). Subtypes are also documented to differ
in co-receptor preference with most subtypes favoring the CCR5 co-receptor in early
disease and switching to CXCR4 after disease progression (Cornelissen et al., 1995).
Subtypes A and C, favor the use of CCR5 throughout the infection time course (Peeters
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et al., 1999), while subtype D utilizes both receptors (Kaleebu et al., 2002). Overall,
knowledge of the infecting genotype is critical for efficient clinical management of infected
individuals (Geretti, 2006).
The current gold standard method for genotyping is phylogenetic analysis (Arens,
1999) since it performs best especially in the case of complex recombinants (Holguin
et al., 2008b). However, such analyses are time consuming and demand expertise in the
meticulous choice and implementation of methods as well as interpretation of results.
Over the past decade, some rapid and semi-automated genotyping procedures have been
proposed (Rozanov et al., 2004; Gale et al., 2004; de Oliveira et al., 2005; Gifford et al.,
2006; Wu et al., 2007). The NCBI Viral Genotyping Tool (Rozanov et al., 2004) and
the Recombination Identification Program (RIP) (Gifford et al., 2006) use BLAST-based
similarity scores of a test sequences against a set of reference sequences for an overlapping
set of windows to determine the most similar reference “parental” type in each window.
Similar to this approach, STAR (Gale et al., 2004) finds the closest sequence from a
reference set of pol sequences. The REGA genotyping tool (de Oliveira et al., 2005)
genotypes a test sequence using binary decision trees based on fixed reference sets. Wu
et al. (2007) proposed a method for representing sequences as complete composition
vectors (CCV) that summarize sequences based on observed and expected frequencies of
oligomers. The NCBI and RIP tools require further phylogenetic confirmation (Rozanov
et al., 2004; Gifford et al., 2006) and “human” decisions to genotype test sequences based
on plots produced. CCV struggles with accurate genotyping of CRFs (Wu et al., 2007).
Several independent studies have shown many discrepancies among these genotyping
methods (Gifford et al., 2006) and difficulties in particular, identifying non-B subtypes
and recombinant forms (Holguin et al., 2008b).
Rajaram and Dorman (2009) showed that of four popular supervised learning
methods– Classification and Regression Trees (CART), Random Forests, Na¨ıve Bayes
and Bayesian Additive Regression Trees (BART)– BART performed best, especially
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for complex HIV data that included unique recombinants. We present an ensemble
HIV-1 genotyper comprised of several binary BART classifiers, one for each HIV-1 geno-
type. Together, these determine the genotype of the input sequence. We present results
from using uncorrected distances or oligomer frequencies with both performing com-
parably on our test dataset. Further, we address some challenges supervised learning
algorithms face when applied to HIV genotyping due to the skewness in available HIV
data and present some solutions to deal with the same. A genotyping tool based on
classification by BART is available for download as well as through a web interface at
http://www.biomath.org/HIVgenotyper.
3.2 Methods
3.2.1 Classification with Bayesian Additive Regression Trees (BART)
Classification by supervised learning algorithms is achieved by the use of explanatory
feature sets X = (X1, . . . , Xl) to predict a categorical response Y . Feature sets are
usually numerical summaries of a test entity that may help explain the response Y .
These methods require a training set that provides feature representations for entities
similar to the ones we wish to test or classify. Additionally, it is necessary to provide the
true assignment of the Y response variable for the training set. The learning algorithm
then uses the training data to formulate “rules” that may be followed to obtain the
classification for a test entity. Needless to say, the quality of the training data heavily
impacts the success of a classifier. Additionally, the nature of the data may make some
learning algorithms better for certain types of data than others.
BART achieves classification using a “sum-of-trees” model (Chipman et al., 2008)




g(X;Tj, µj) + ,  ∼ N(0, σ2)
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where each g(X;Tj, µj) is a classification/regression tree with structure Tj and terminal
node parameters µj. A classification/regression tree has a binary structure. At each
internal node, a “rule” splits the data arriving at the node, sending it down the left or
right subtree depending on its value. Rules are formulated so they achieve the best split
of the data. For example, a node may have a “variable z > 0.9” as a rule. Suppose that
there are n sequences/data points in the test set of which, k satisfy this rule. Hence,
the left subtree of the node will receive the k data points that have a value greater
than 0.9 for variable z and the remaining n − k data points will be passed down the
right subtree. Trees are grown by recursively applying the above method. Applying
the rules, each data point falls in exactly one leaf of each tree. The leaves of each
tree contain the mean regression value for its constitueent data points. In BART, the
final prediction is the sum of the regression values predicted by m trees. BART guards
against overfitting of data by placing a regularization prior on the height of each tree.
This prior forces each tree to be a weak-learner thus preventing it from growing too tall
and dominating the result. For classification of a binary response the BART model uses
the probit link function (Chipman et al., 2008; Zhang and Hardle, 2008). The predicted
outcome is in the form of a continuous variable that is thresholded at 0.5 to make a
binary classification.
3.2.2 Feature Representation
Feature representations used in the current study can be broadly classified into align-
ment based features and non-alignment based features. Alignment based features are
obtained by characterizing the relatedness of a sequence to a reference representative
of a genotype of interest from pairwise sequence alignments involving the two. On the
other hand, non-alignment based features simply decompose every sequence into a set
of numerical coordinates and use the resultant vectors to compare with the vectors ob-
tained members of the training set to classify. It must be noted that these are only a few
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types of representations and may be changed for other representations that may yield
better prediction for specific sets of sequences.
Alignment based features: The alignment-based features used in this study sum-
marize a sequence in terms of its “similarity” with parental genotypes. In order to have
a standard set of parental genotype sequences to which to compare and generate these
features, we curated a Reference Set. The 2009 complete genome reference sequences
was downloaded from the HIV database (HIV-Database, 2010). We reduced this refer-
ence set to contain one representative sequence per subtype/CRF by using consensus
sequences when three or more representative sequences were present. When only two
representative sequences were available, one was chosen randomly. Because recombinants
are expected to differ in relatedness to a single reference genotype across their genome,
a global full length measure does not quantify the relatedness metric accurately. To ad-
dress this concern we used a sliding window based method to obtain a vector of pairwise
relatedness measures for a query sequence with each reference genotype.
The simplest measure of relatedness is uncorrected distance. The UD feature set
refers to the collection of vectors specifying the relatedness of query sequences to a
reference genotype. Specifically, UDj refers to a matrix storing the uncorrected distance
of all query sequences against a specific genotype j, with each query sequence represented
by a row and columns representing consecutive windows.
Non-alignment based features: Alignment based features, while very effec-
tive (Rajaram and Dorman, 2009) come with the overhead of having to build alignments.
This can be very time consuming for a large batch of sequences. Although, in the case of
training sequences, this may only be a one-time investment. We borrowed from the idea
of Wang et al. (2007) and summarized each sequence as a vector of frequency of occur-
rence of certain oligomers. The reference set was used with the CCV program described
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in Wang et al. (2007) to obtain a list of the top 5000 most informative oligomers ranging
from size 7 to 21 bp. Counts of occurrence of each of these 5000 oligomers constituted
the Kmer feature set.
3.2.3 Classification with Binary Classifiers
We achieved genotyping using a set of one-versus-all binary classifiers. For each
genotype we wished to test, we built a binary classifier. The classifier for genotype
j trained from feature representations of training sequences that had response Yi = 1
if their true genotype assignment contained at least one fragment of genotype j and
0 otherwise. Trees trained thus were then used to classify test sequences for which Y
values are unknown to the classifier. Final genotyping results were obtained by listing all
the genotypes for which a particular test sequence got a positive classification. Fig. 3.1
describes the binary classification process.
3.2.4 Cross-validation
In order to test the efficacy of our classifiers and to make sure that they are not
inordinately affected by choice of training and test data, we performed a 5-fold cross
validation test. At each fold, 4/5ths of the data was used to train a classifier and the
held-out 1/5th was used to test it. Denoting true positives (negatives) TP (TN) and false
positives (negatives) FP (FN), P = TP+FN , N = FP+TN , P ′ = TP+FP , andN ′ =
TN+FN , we report accuracy (TP+TN)/(P+N), specificity TN/N , sensitivity TP/P ,
precision TP/P ′, Matthew’s correlation coefficient (MCC = TP×TN−FP×FN√
P×N×P ′×N ′ ) and F-
measure (F = 2·precision·sensitivity
(precision+sensitivity)
). Precision, MCC and F-measure are recommended
assessments for imbalanced datasets (Chawla, 2006).
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3.3 Data
3.3.1 Full length Dataset
To create a relevant dataset for an evolving virus now sequenced for several decades,
we chose the most recent 500 sequences. Genotypes with less than 5 full length genome
representatives had to be eliminated from this dataset in order to be able to use it for a
5-fold cross validation study, leaving us with 18 genotypes. To insure fair representation
of all 18 genotypes, we randomly substituted highly-represented genotypes with older,
under-represented genotypes, until there were at least 5 full-length genomes for all 18
genotypes. The final dataset (shown in Table 3.6) included 337 pure subtype nonrecom-
binants, 34 URFs of pure subtypes, 112 CRF sequences and 17 URFs with at least one
CRF parent. Datasets and accession numbers can be found at
http://www.biomath.org/HIVgenotyping.
3.3.2 Gag Dataset
This dataset consists of all publicly available gag sequences representative of HIV-1
group M (HIV-Database, 2010). Of these we randomly chose 100 sequences to form a
Test Gag set while the remaining 3, 937 were used to form the Training Gag Set.
3.3.3 Full length Supplemented Dataset
This dataset was curated to be used to train trees on all genotypes for the full length
HIV genome. Starting with all 1, 776 publicly available full length HIV-1 sequences as
of September 2008, we supplemented all under-represented CRFs and subtypes with 10
synthetic non-recombinant and 10 synthetic recombinant sequences (method described
in later sections). The resultant dataset had 2, 676 sequences.
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3.4 Challenges
3.4.1 Dealing with Imbalanced Data
It is obvious from a glance at Table 3.6 that the distribution of available data by
genotype is heavily skewed. In the case of classification, this creates a problem, especially
for classifiers of under-represented genotypes. Consider a case where all known full-
length genomes are used to train a classifier for genotype CRF42 BF. The training set
will then have 17 positive cases versus 1, 759 negative cases. Metrics of accuracy are
misleading in such cases since predicting all cases as negative still gives the classifier
a 99% accuracy. Provost (2000) and Chawla (2006) point to adjusting thresholds as
a means of dealing with such situations. Instead of fixing the threshold at 0.5 for
a classification problem, we optimize it, so as to minimize errors and achieve correct
classification of the positive cases as well.
3.4.2 Supplementing Data with Synthetic Recombinants: bootSMOTE
For emerging recombinant forms, however, we are further hampered by having very
little information. For many CRF types we have two or three sequences that also tend
to have very little diversity. Training on one or two and testing on the remaining
therefore works well currently but is not expected to deal well with future diversity.
Unique recombinant forms, as also newer CRFs involving these heavily underrepresented
genotypes, may end up misclassified due to lack of training data. In order to provide a
little more balance to the training data we propose to supplement with synthetic data
that we generate using a novel technique, bootSMOTE. This method uses the general
idea of a bootstrapping and applies it as a Synthetic Minority Oversampling TEchnique
(SMOTE) proposed by Chawla et al. (2002) to deal with imbalanced datasets. Synthetic
variants were created using M ≥ 2 “real” non-URF sequences of a genotype in a multiple
sequence alignment of length N . For each position l ∈ 1, 2 . . . N of the new variant, a
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“real” sequence j ∈ 1, 2 . . .M was chosen at random and the nucleotide in its position
l was used. The resultant set of variants remained close enough that they formed a
monophyletic group with their respective real sequences. At the same time, they had
more variation, albeit synthetic, that may better represent the variation in hitherto
unseen members of the genotype.
To produce a synthetic recombinant, the number of breakpoints was considered to
be a Poisson random variable with a user defined mean value (e.g. a mean of 0.3
breakpoints produces 80% nonrecombinant sequences and tends to limit the number of
breakpoints to a maximum of two). Conditional on the number of breakpoints, their
location was allowed to be uniform over the length of the entire genome ensuring that
each fragment was at least 200 bp long. For each fragment, a genotype was chosen
at random constraining only for chosen genotypes to be different across a breakpoint.
Individual fragments were then constructed using the bootSMOTE method described
above using non-URF training sequences of the chosen genotype. Figure 3.2 provides a
schematic representation of the bootSMOTE technique.
3.4.3 Using Partial Genome Trees
Another type of paucity of data arises when faced with partial genome sequences. It
is important to examine if and how missing data, due to lack of sequence information
of a test sequence affects performance by a classifier that has been trained on longer
sequences. We trained trees using the Gag Training set and feature sets UD and Kmer.
We also trained trees for the teo feature sets using the Full length supplemented set.
The Gag Test set was used to test all these classifiers. Further, we truncated the 100
sequences in the Gag Test Set by 250bp and 500bp at the 3’ end and used the gag trained
trees to classify these.
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3.4.4 Software
The source code for the genotyper contains a Perl wrapper script that calls the
classification routine from a C++ library. The C++ library is a modified version of
the BART R package (Chipman et al., 2008). The code may be used to train and
store classifiers using a training set of sequences. Alternately, stored classifiers may be
provided to the code to be used for classification of test sequences. A web interface for
the HIV-1 genotyping tool can be found at http://www.biomath.org/HIVgenotyper.
This interface has a PHP front end and the Perl–C++ code at the back end. The web
form accepts test sequences from users as raw sequences as well as feature sets. Also, it
provides the user with pre-made trees that may be used for classification. Results are
displayed in simple text format.
Pre-made classifiers: Currently, the genotyper provides two sets of pre-made
trees, both trained on the Full length supplemented dataset. For the first set, the UD
feature set was computed using the Reference Set and used to build the training trees.
The second set was built using feature set Kmer corresponding to the training set.
Having pre-made trees makes classification of new test sequences virtually instantaneous
since it does away with the time overhead of training.
3.5 Results
For alignmemt based features, we used window sizes of 300 bp placed every 100 bp.
This choice is arbitrary and any choice is suitable as long as there is considerable overlap
between successive windows (data not shown). Table 3.2 provides details of performance
of classification using various combinations of methods and feature sets. Performance
measures reported are mean values across the 5-fold cross-validation runs with standard
errors in parentheses. Holguin et al. (2008a) found the NCBI viral genotyping tool to
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be better than STAR and REGA in classifying CRF06 cpx sequences. In the current
analysis we found that all three methods, NCBI, REGA and CCV were able to classify
pure subtype sequences almost faultlessly, as was our genotyping tool, regardless of the
feature set that was used. REGA and NCBI had difficulties specially when confronted
with CRFs or URFs that are not part of the reference set. NCBI allows for a user
submitted reference set and performance improved for CRFs with a more relevant ref-
erence set while URFs were still hard for the NCBI tool to classify. The CCV method,
on the other hand, had some difficulty with classifying CRFs even when they were in
its reference set and had very limited success with complex URFs. For both the NCBI
and CCV output, the closest n predicted parental types were taken as the classification
provided by the method where n is the number of real parental genotypes of the test
sequence. BART handled CRFs present in the reference dataset with ease. Both the
Kmer and UD datasets perform comparably. Additionally, our genotyper was able to
correctly classify most URFs except in cases where a fragment was particularly small.
3.5.1 Using Synthetic Recombinants
Training and test datasets were created to simulate the current state of data avail-
ability on certain genotypes. Some have only two representative sequences and it is
possible, with the fast evolving nature of the virus, that newer sequences involving these
genotypes evolve. In cases such as these, the training data available is insufficient for
efficient classification of emergent complex forms. To test such scenarios we used, as an
example, the subtype D classifier trained on feature set UD. In the Full length dataset,
subtype D is represented by two non-recombinant sequences and four URFs containing
fragments of subtype D. While the non-recombinants were identified correctly, the clas-
sification of the URFs suffers from lack of training information. Fig. 3.3 demonstrates
the use of bootSMOTE synthetic recombinants to enhance classification. We generated
50 synthetic non-recombinant sequences using the two non-recombinant D sequences
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already present in our dataset. However, supplementing with these made no difference
to identification of the D fragment in the four URFs (black line in Fig. 3.3).
Not included in our current dataset are 54 non-recombinant D sequences that were
eliminated in favor of more recent representatives. We chose three of these randomly to
see if the identification of URFs improved. Supplementing with just the non-recombinant
sequences results in two URFs being identified (blue line is Fig. 3.3). However, supple-
menting with 10 synthetic sequences generated from three non-recombinants leads to
identification of one URF (red line in Fig. 3.3). This performance is matched with only
four synthetic nonrecombinants generated from four real sequences.
To test if supplementing with synthetic recombinants improves performance we gen-
erated 50 synthetic recombinants with at least one fragment belonging to the D genotype
generated using only the 2 nonrecombinant sequences that were part of the Full length
dataset. Supplementing with 30 synthetic recombinants results in identification of the
two URFs previously identified.
When real data is available in the form of only two sequences, the similarity of the
available sequences is bound to affect any synthetic sequences generated from them and
consequently classification achieved by training on these synthetic sequences. To study
the effect of the level of similarity of real sequences we started with four pairs of non-
recombinant B sequences with varying pairwise uncorrected distances ranging from 0.0
to 0.1451. Fifty synthetic recombinants were generated from each pair. Each synthetic
recombinant had at least one fragment belonging to subtype B, generated from the
original pair of B sequences. Classification of the synthetic recombinants was attempted
by using just the real B sequences as training data and later supplementing the training
data in steps of 10 synthetic sequences. Table 3.6 presents results from this analyses.
For closely related sequences, there was a high success rate of true positive identification
with this rate reducing to almost 0 with increasing distance between the pair of parents,
when the UD feature set was used. In the case of using the Kmer feature set, even
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closely related parental pairs only result in a true positive rate of ∼ 50% although
we still see the trend of smaller true positive rates with increasing distance between
parents. Interestingly, supplementing with 10 synthetic recombinants improves this rate
considerably in all cases. To complete the picture, we used recombinants created using
pair one as a test set while using pair four as the training set. Supplementing the training
set with 10 recombinants made from pair four improved the true positive identification
from 80 to 96% in the case of using the UD feature set and from 48 to 100% in the case
of the Kmer feature set.
3.5.2 Partial Genome Trees
It is common for researchers to sequence only a part of the genome. In cases like
this, using classification trees trained on longer data may result in poor classification.
To test this premise, we classified sequences in the Gag Test Set using the pre-made full
length training trees described in section 3.4.4 as well as Gag Train Set with feature
sets UD and Kmer. Table 3.6 shows results of classification success with both these
training scenarios using both the UD and Kmer feature sets. While using trees trained
on gag sequences, classification using the UD feature set is comparable to earlier results
in Table 3.2. However, using trees trained on full length data, affects the outcome
considerably. Interestingly, with the Kmer feature set, even trees trained using gag
sequences have somewhat lowered classification power. Table 3.6 also shows classification
performances of UD trees trained on the gag sequences while classifying truncated Gag




In this study, we presented a novel application of supervised learning algorithms to
the very pertinent problem of rapid HIV-1 genotyping. In order to deal with recom-
binants, we implemented a dedicated binary classifier for each genotype of interest so
that a test sequence has the opportunity to be classified simultaneously within several
genotypes. This approach leads to near accurate classification of not only known CRFs
but URFs as well.
The skewed sampling of HIV-1 sequences, with some genotypes represented more
than others and some regions of the genome sequenced more than others. This leads to
a variety of situations that provide little or no data, necessitating the exclusion of some
genotypes from the ensemble genotyper. In order to include genotypes with insufficient
data and hence build a more complete genotyper we proposed supplementation with
synthetic sequences generated using the bootSMOTE method. As illustrated using the
case of genotype D, the classifier accurately identified the two full length sequences,
however, failed to classify the four URFs containing genotype D also in the Full length
dataset. In an evolution of the virus, with more and more recombinants surfacing as
viable pathogens, training on just non-recombinant sequences may not work well. We
encounter this scenario in the example of the D classifier where even when supplemented
with fifty synthetic sequences generated from the two non-recombinant D sequences,
none of the URFs were identified. However, addition of just one more non-recombinant
D sequence to the data used to generate synthetic variants, leads to success in identifying
one URF. However, in most real cases, we may only have two or three sequences. In
such cases, this example also demonstrated the power of using synthetic recombinant
sequences for supplementation. These synthetic recombinants, even when originating
from just two non-recombinant sequences lead to successful identification of two URFs.
In two of the four URFs the D fragment still remains unidentified. It is possible that
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the fragments are too small for detection with our current feature sets.
We explored the power of supplementation with synthetic recombinants more with
the experiment involving pairs of B sequences. The number of synthetic sequences
required for fully accurate identification of all recombinants in the test set increased with
increasing pairwise distance between the original pair of real sequences. However, all
recombinants were eventually identified successfully. Synthetic recombinants supplement
data in many ways. In the case where the pair of B sequences were very close (pairwise
uncorrected distance = 0.0), the B fragments of all synthetic recombinants will naturally
be very similar to each other as well as the parental sequences. However, even with such
striking similarity, the classifier was not able to correctly classify all of them when trained
only on real data. This is possibly because recombinants lack the complete signature
that the trained classifier would have identified in the real data. Including recombinants
in the training set allows the classifier to calibrate to instances where only a fragment
in the entire sequence belongs to the B genotype i.e. synthetic recombinants inform on
structure. Cases with divergent real data need more help. In these cases, not only do
the synthetic recombinants inform on structure, they now also make up for paucity in
content. Diversity of the parental sequences has direct bearing on the diversity in the
synthetic recombinant. Thus, when tested with one such synthetic recombinant, the
classifier has to identify a fragment and classify as belonging to the B genotype. The
dual information provided by the synthetic recombinants in such cases is reflected in the
increasing number required to classify all the test recombinants correctly.
The use of specialized training sets is a strength of this method. As illustrated in the
example using partial genome trees, missing sequence data can be highly detrimental
to efficient classification. Using training sequences that are comparable in length and
covering the same genomic region produces best results. Both feature sets perform well,
albeit, a little worse than their classification performance on the Full length dataset. The
short length of the region may yield much less information for the classifier to train on.
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Attempts at using classifiers trained on full length sequences produced poor results. In
order to use these classifiers, we disregarded all trees that contained split rules involving
missing data. This greatly reduces the number of trees used in the final classification
and potentially loses the granularity required to distinguish a recombinants from its
non-recombinant parent. Similar results are obtained when the classifiers trained on the
Gag Training dataset where tested using truncated gag sequences.
The adaptability of this genotyper to the use many different relatedness measures
and ability to incorporate additional sources of information or very large sets of co-
variates is a big asset. Rajaram and Dorman (2009) demonstrated the use of two other
alignment based features that performed nearly as well as the UD feature set. It is
possible to provide other feature sets such as distances to genotypes other than the
target genotype (preliminary analysis shown in Rajaram and Dorman (2009)) or even
bootscan results (Salminen et al., 1995). Further, multiple information such as distance
and phylogenetic measures could be combined.
Phylogenetic based recombination detection tools (Gale et al., 2004; Husmeier and
McGuire, 2003; Grassly and Holmes, 1997; Suchard et al., 2003; Minin et al., 2005),
while successful, are slow particularly in the case of complex recombinants that may
require inclusion and analysis of multiple putative parental genotypes. Though a more
thorough window-by-window application of supervised learning algorithms could provide
an estimate of recombination breakpoints, we envision this method as a rapid screening
tool that may be followed up by phylogenetic detection analyses. In such a case, this
tool can greatly decrease the list of putative parents of complex recombinants thereby
shortening the time taken for downstream analyses. While training classifiers takes time,
it is modest compared to phylogenetic analyses and is a one-time cost. The classification
of test sequences using pre-made classifiers is virtually instantaneous. Analysis of a test
sequence with BART-UD takes about eight seconds on a modern 64 bit server; REGA
and NCBI were reported to take about 10 seconds per test sequence (de Oliveira et al.,
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2005).
Users may use the source code to train and store classifiers most pertinent to the
test data they wish to classify. For example, reference and training sets specific to a
geographical region may perform better classification of more sequences from the same
region. The web interface provides users with the opportunity of rapidly genotyping
their test sequences using pre-made classifiers. It is proposed to add more pre-made
classifiers to the interface pertaining to specific regions of the genome as well as different






















Figure 3.1 The ensemble genotyper setup with a binary classifier represent-
ing each genotype. Final classification is a list of all positive
classifications from the ensemble.
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(a) Creating synthetic non-recombinants
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(b) Creating synthetic recombinants
Figure 3.2 (a) bootSMOTE for creating synthetic non-recombinants start-
ing with an alignment of M real non-recombinant sequences. At
each position 1 ≤ i ≤ n one sequence from the alignment is cho-
sen randomly and used in synthetic sequence. (b) bootSMOTE
procedure for creating synthetic recombinants. Here, k = 2
breakpoints are placed at positions i and j. Parental genotypes
are chosen for each fragment. Synthetic recombinant is gener-
ated by concatenating fragment sequences generated as shown
in (a).
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Figure 3.3 Classification of URFs by subtype D classifier upon supplemen-
tation. Plot showing number of URFs identified with addition
of synthetic variants in steps (x-axis). NR (Rec) denotes use
of nonrecombinant (recombinant) variants for supplementation.
The number 2, 3, 4 or 5 denotes the number of real D sequences
used to create synthetic variants.
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Genotype U S/C Genotype U S/C
CRF 01 AE 10 20 CRF 02 AG 6 27
CRF 06 cpx 2 7 CRF 07 BC 1 5
CRF 08 BC 0 5 CRF 09 cpx 1 5
CRF 11 cpx 0 6 CRF 12 BF 0 5
CRF 13 cpx 0 5 CRF 14 BG 0 5
CRF 15 01B 0 5 CRF 42 BF 0 17
A1 13 22 B 33 74
C 21 235 D 4 2
F1 12 1 G 3 3
Table 3.1 Distribution of genotypes in full length dataset, showing counts


















































































































































































































































































































































































































































































































































































































































































Training Tree Acc. Spec. Sens. Prec. MCC F
Gag - UD 0.967 0.983 0.832 0.852 0.824 0.842
Gag - Kmer 0.964 0.988 0.771 0.895 0.811 0.828
Full - UD 0.582 0.559 0.8 0.160 0.211 0.267
Full - Kmer 0.573 0.545 0.817 0.173 0.221 0.286
Analyses of truncated Gag Test Sets using the Gag-UD training trees
Test Set Acc. Spec. Sens. Prec. MCC F
Gag - 250bp 0.537 0.524 0.643 0.136 0.103 0.225
Gag - 500bp 0.491 0.489 0.510 0.131 −0.0004 0.209
Table 3.4 Classification performance using classifiers trained on Gag se-
quences and full length sequences and tested using Gag test se-
quences.
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CHAPTER 4. HOT AND COLD: SPATIAL
FLUCTUATION IN RECOMBINATION RATES
A paper published in the Proceedings of the 7th Annual IEEE Bioinformatics and
Bioengineering Conference,2007
Misha L. Rajaram, Vladimir N. Minin, Marc A. Suchard and Karin S.Dorman
Abstract
Coinfection of a single cell with two or more HIV strains may produce recombinant
viruses upon template switching by the replication machinery. We applied a hierarchical
multiple change point model to simultaneously infer inter-subtype recombination break-
points and spatial variation in the recombination rate along the HIV-1 genome. We
examined thousands of publicly available HIV-1 sequences representing the worldwide
epidemic and focused on 544 unique recombinants with 1, 701 recombination breakpoints.
Estimates of per site recombination rate revealed the presence of a novel hotspot in the
pol gene, surrounded by a cluster of mutations associated with resistance to reverse
transcriptase inhibitors. We also confirm the presence of a known hotspot in the env
gene and a previously hypothesized hotspot in the gag gene.
4.1 Introduction
As if to achieve a primitive kind of sexual reproduction (Temin, 1991), retroviruses,
including Human Immunodeficiency Virus (HIV), package two positive sense RNA parti-
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cles and a strand-switching reverse transcriptase enzyme in each virion. Even genetically
distinct strains can be copackaged (Hu and Temin, 1990), and with documented cases
of superinfection of both hosts (Chohan et al., 2005; Fang et al., 2004; Hu et al., 2005)
and cells (Levy et al., 2004), all ingredients necessary for recombination to mold the
AIDS epidemic are in place (Peeters, 2000). Here we focus on the in vivo spatial dis-
tribution of strand transfer events along the genome to learn about the mechanism and
selection of recombination in HIV type 1. The error-prone reverse transcriptase (RT)
has produced pronounced variation in HIV (Wain-Hobson, 1993). Viruses around the
world have been classified into subtypes (e.g. A), circulating recombinant forms (e.g.
CRF01 AE), and subsubtypes (e.g. A1) (Robertson et al., 2000). All major subtypes
have long co-circulated in Africa, but subtype mixtures are increasingly common in other
parts of the world (e.g. (Bello et al., 2007; Cuevas et al., 2002)). With few barriers to
limit recombination between genetically diverse strains (Baird et al., 2006b; Chin et al.,
2007), the prevalence of recombination seems destined to increase as the epidemic pro-
gresses. The capacity to recombine diverse viral strains is almost certainly a benefit to
retroviruses (Burke, 1997; Worobey and Holmes, 1999).
HIV recombinants have successfully out-competed other strains within hosts (Fang
et al., 2004; Salminen et al., 1997), and inter-subtype recombinants have been alarmingly
successful at causing (e.g. (Liitsola et al., 1998; Piyasirisilp et al., 2000)) or taking
over (Tee et al., 2005) local epidemics.
With recombination thus driving HIV evolution, it is important to uncover the mech-
anism of strand transfer. Increasing experimental and observational evidence suggests
that strand transfer events do not occur uniformly along the genome. There have been
several hints of a hotspot in the 5’ portion of the pol gene, both in experiment (Jetzt
et al., 2000) and among in vivo recombinants sampled from patients (Magiorkinis et al.,
2003; Thomson et al., 2004). Another well studied hotspot is the conserved C2 region of
env (Moumen et al., 2001; Quinones-Mateu et al., 2002), although all conserved regions
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in env are relatively hot (Baird et al., 2006a) and even variable regions can become
hotspots with the right donor template (Baird et al., 2006b). Many inter-subtype re-
combinants observed around the world display a recombinant pattern where the variable
loop V3, between C2 and C3 (Renjifo et al., 1999), or the complete gp120 portion of
env (Takebe et al., 2003) is swapped with another subtype. Other regions implicated
as possible hotspots are 5’ gag (Dykes et al., 2004), the gag-pol boundary (Magiorki-
nis et al., 2003), the pol -vif boundary (Derebail et al., 2003), through vif into the 5’
env (Magiorkinis et al., 2003), a GC-rich region near the tat/rev splice site (Douglas
et al., 1996), and near nef (Magiorkinis et al., 2003). Indeed, very few genomic regions
are consistently “cold,” but few studies have examined the entire genome at once and
experimental protocols and reagents vary widely.
There is no single determinant of retroviral recombination, but at least secondary
structure, reverse transcriptase pausing, and sequence homology influence transfer rates
(see recent review (Galetto and Negroni, 2005)). The recombination enhancing role of
nucleocapsid (Negroni and Buc, 2000) suggests the importance of secondary structure,
and the TAR stem loop is one structure known to facilitate strand transfer (Berkhout
et al., 2001; Kim et al., 1997). Recombination in the env C2 region depends on homol-
ogy between the donor and acceptor templates, a stable stem loop in the acceptor, and
to a lesser degree, primary sequence (Galetto et al., 2004, 2006; Moumen et al., 2003).
Homology at the dimerization signal (Chin et al., 2007; Moore et al., 2007) and through-
out the genome enhances inter-molecular strand transfer (Andersen et al., 2003), most
importantly at the strand transfer site (Baird et al., 2006b; Gao et al., 2007). It was
recognized early that strand transfers tend to occur at pause sites of reverse transcrip-
tion (Wu et al., 1995; Lanciault and Champoux, 2006), so it is not surprising that regions
prone to form stem loops (Zhang et al., 2005) and homopolymeric stretches (Baird et al.,
2006a) are positively correlated with strand transfer, since they are both associated with
pause sites (Klarmann et al., 1993).
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The study of in vivo recombination has revealed a non-uniform distribution of trans-
fer sites along the genome (Magiorkinis et al., 2003; Renjifo et al., 1999; Takebe et al.,
2003; Thomson et al., 2004; Zhang et al., 2005). Inferred breakpoints do not directly re-
veal mechanistic hotspots of recombination, because these viruses can replicate in hosts
and are thus highly selected. In fact, even the selection imposed by multi-cycle in vitro
recombination assays can change the genomic distribution of strand transfer sites (Baird
et al., 2006a). However, we expect strong mechanistic hotspots to leave a signal even
after heavy selection. Furthermore, hotspots emerging only post-selection inform on the
forces molding the current AIDS epidemic. We have applied a hierarchical model for
estimating spatial recombination rates (Minin et al., 2007) to a large dataset of recom-
binant sequences and identified striking nonuniformities in the distribution of strand
transfers along the HIV-1 genome.
4.2 Methods
4.2.1 Reference Alignment
We downloaded the 2003 reference sequences from HIV-Database (2010), which in-
clude full-length sequences representative of each major HIV subtype, circulating recom-
binant form, and subsubtype. From these reference sequences, consensus sequences for
nonrecombinant subtypes (or subsubtypes) A1, A2, B, C, D, F1, F2, G, H, J, and K
created by the HIV Database Consensus Tool were realigned using T-Coffee (Notredame
et al., 2000), and gaps were trimmed from the alignment ends.
4.2.2 Screening for Recombinant Sequences
We downloaded all HIV-1 sequences present in Genbank as of May 17, 2005 at
least 400 nucleotides long and discarding patent and other non-natural sequences. Each
sequence was aligned to the consensus alignment and the alignment trimmed of gaps at
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both ends. To eliminate sequences with very tight epidemiological linkage, we identified
groups of sequences with sequential accession numbers, similar lengths (alignments vary
less than two nucleotides), and similar sequences (pairwise Hamming distance less than
0.01). One random sequence was selected from each group and all others were not further
studied. The resulting data set included 64, 603 HIV-1 sequences.
To reduce the dataset, we analyzed each alignment using cBrother software (Fang
et al., 2007), which estimates, via Markov Chain Monte Carlo (MCMC), recombination
in a single sequence (Minin et al., 2005). We did not fix the tree relating potential
parental subtypes, in order to account for inconsistent relationships among subtypes
along the genome (see Fig. 5 of (Anderson et al., 2000)) and ancient recombination
among subtypes, which can bias recombination inference if neglected (Fang et al., 2007).
cBrother is inefficient when there are more than six parental sequences and the
parental tree is not fixed, so we prepared six separate alignments, each with a subset
of five or six parental strains. All pairs of parents are included in at least one of these
alignments, so we were able to detect all simple recombinants involving just two parents.
For each alignment, we produced an MCMC sample from a short run of length 110, 000,
discarding 10, 000 and subsampling every 100. Otherwise, default settings were used.
There were 9, 819 simple recombinants detected at this stage. When more than one
alignment contained the involved parents, we randomly selected one MCMC sample for
future analysis.
We prepared the remanining sequences for more thorough examination, to avoid
convergence issues that the intial short runs of MCMC may have suffered. First, we
clustered sequences with similar recombinant structure. Clustering on structure serves
to eliminate recombinant forms that are descendents of the same recombination event.
Their inclusion could falsely inflate recombination signal near their breakpoints. We
defined the profile structure of a recombinant as the 5’ to 3’ sequence of parents that
are supported with a posterior probability of 0.9 or higher and the posterior medi-
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ans of all breakpoints separating adjacent parents. Posterior breakpoint medians and
95% Bayesian credible intervals were computed from the MCMC sample. We clustered
sequences with similar structures, i.e. the same parents and co-located breakpoints. Co-
located breakpoints were those where either 95% Bayesian credible interval contained
the other recombinant’s posterior median breakpoint. After randomly selecting one se-
quence to represent each cluster, there remained 4, 073 sequences. These sequences were
analyzed with two independent cBrother runs of length 1, 100, 000, discarding 100, 000
and subsampling every 1, 000. We used several convergence diagnostics, including the
Gelman-Rubin statistic (Gelman and Rubin, 1992) and all CODA (Best et al., 1995) test
statistics with default settings except in the Raftery & Lewis statistic, where convergence
was diagnosed for the 0.025 quantile at a precision of ±0.02 and 90% certainty. Most
samples were converged after the initial run, but run lengths were doubled until con-
vergence was achieved for all unconverged samples. After discarding nonrecombinants
or complex recombinants identified in the second run, we were left with 2, 360 simple
recombinants. Clustering again on profile structure resulted in 544 unique recombinants,
representing 1, 701 unique breakpoints.
4.2.3 Estimation of Genomic Recombination Rates
Recombinants involving multiple subsubtypes, both B and D and those with subtype
K as parent were rarely seen. We, therefore, reduced the number of parents by letting
A1 represent subsubtypes A1 and A2, F1 represent F1 and F2, and B represent closely
related D (Cornelissen et al., 1997) and removing subtype K. The final, reduced list of
parental subtypes was A, B, C, F, G, H and J.
The hierarchical model for combining evidence from multiple recombinants (Minin
et al., 2007), implemented in the software BandOfBrothers, seeks to estimate recombi-
nation rates ps, the probability of recombination at site s ∈ {1, . . . , S}, along a master
alignment of length S containing parental sequences and all recombinants. The model
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is developed in terms of the log odds of recombination γs = log
ps
1−ps . To constrain
the number of free parameters, it places a Gaussian Markov Random Field (Rue and
Held, 2005) hyperprior on the parameters γs and assumes these parameters are corre-
lated for neighboring sites. Evidence that HIV recombination hotspots are not so much
spots, rather regions, where strand transfers cluster (Galetto et al., 2006), supports this
correlation assumption.
We prepared four data sets: (1) full genome, and three gene-focused datasets (2)
gag, (3) pol, and (4) env. We experienced difficulties obtaining a master alignment for
the full genome because of the variability in the lengths of the individual recombinants.
This master alignment is needed by BandOfBrothers to map breakpoints inferred in
individual recombinants to the common indexing system s. Our solution was to prepare
individual alignments of each recombinant to the full-length reference sequence HXB2
used for numbering genomic positions in HIV-1 (Korber et al., 1998). Then, all break-
points along the individual recombinants were mapped to their HXB2-relative position.
Using this strategy, we lose detailed positional information about breakpoints found
within insertions in the recombining parental reference sequences that are not in HXB2.
Fortunately, such insertions are rare. Gene-specific master alignments were obtained
without difficulty.
The full genome alignment consisted of 544 unique recombinants. The gene-focused
alignments consisted of all recombinants with recombinant profile breakpoints falling in
the selected gene. Only the gp120 portion of env was considered in the env dataset, as
this is where most studies of experimental recombination have focused. The number of
recombinants included in each dataset are 93 in gag, 167 in pol, and 179 in env.
An MCMC sample of the hyperprior parameters ps was obtained using BandOf-
Brothers. Briefly, the software starts by sampling from the lower level multiple change
point model independently for all recombinants and then alternates between updates
of the hyperprior and updates of the lower level change point model conditional on the
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hyperprior. Runs used 1, 000 initial samples, then 110, 000 iterations with 10 lower level
updates per cycle. We subsampled every 20th iteration after discarding the first 10, 000.
All other tuning parameters and hyperparameters were set as suggested (Minin et al.,
2007).
4.2.4 Analysis of Correlates of Recombination
We considered the relation between recombination rate and two simple features of
the genomic primary sequence: GC content and diversity. The posterior distribution of
recombination probabilities along the HIV-1 genome is summarized in Fig. 4.1, along
with a map of genomic features. Plotted are the posterior median (line) and 95% pos-
terior credible set (shading) for the recombination probability ps at each site s of the
HXB2 genome. We caution that the tested sequences were selected because they were
known recombinants, so only relative recombination probabilities are meaningful. Fur-
thermore, although we show results for the 5’ LTR, the parental reference sequences
were not available in this region, so breakpoints could not be inferred there.
For this analysis, we used the 400 random sequences selected for the full genome
run. GC content at each site is the proportion of guanine or cytosine nucleotides in the
alignment in a window of specified length straddling the site. Window sizes of 20, 50 and
100 nucleotides were used. A per site estimate of diversity was obtained by computing





where psi is the proportion of sequences containing nucleotide i at site s. Hs values
close to zero indicate conserved sites. The R statistics package was used to compute
nonparametric Spearman correlations between these numeric summaries of sequences
and the recombination rates estimated by BandOfBrothers.
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4.3 Results
The distribution of breakpoints along the genome is clearly nonuniform. There is a
blip in the gag gene, though it does not appear significant in the full genome analysis. A
pronounced peak is seen in the pol gene, specifically in the region encoding the reverse
transcriptase. In contrast, the pol sequence coding for the RNase and Integrase are
strikingly cold. The 3’ end of the HIV-1 genome also has higher recombination activity,
particularly at both ends of the env gene. Overall, in vivo recombination breakpoints
in sequences sampled from around the world are most dramatically clustered in the 5’
portion of the pol gene.
We have performed a preliminary analysis to determine whether conservation and
GC content are associated with heightened incidence of recombination. Negative lag
refers to the sequence feature (entropy or GC content) 3’ of the strand transfer site,
while positive lag implies 5’ sequence features. During minus strand synthesis, 3’ fea-
tures are transcribed before strand transfer occurs. Fig. 4.2(a) shows the correlation of
recombination probability ps with entropy Hs computed at each site s. Sequence vari-
ability is positively correlated with recombination, especially 400 or fewer nucleotides
upstream of the transfer site during minus strand synthesis. Fig. 4.2(b) shows corre-
lation of GC content with recombination rate for different window sizes. There is a
negative association of GC content with the site of strand transfer. No correlations are
large, especially considering the fact that the data points are not independent along the
genome. Effective sample sizes estimated with CODA (Best et al., 1995) suggest the
correlations are not statistically significant (data not shown).
We reran the hierarchical model for three local regions of interest: gag, pol, and env.
By focusing on recombinant sequences with known breakpoints in the selected genes, we
expected to obtain better resolution on the location of recombination activity in these
genes. The recombination profile for the gag gene (Fig. 4.3(a)) reveals the blip seen in
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the full genome analysis is significant. The hotspot appears in p24, which encodes the
Capsid protein. As compared to the peak in gag, the pol peak is more dramatic, with
less overlap in credible intervals (Fig. 4.3(b)). Also shown in this plot are the locations
of all in vivo drug resistance mutations mapping to pol (Clark et al., 2005). These
mutations cluster in the common drug target, Protease, and the first half of the other
common drug target, RT. Interestingly, the hotspot is squarely centered on the cluster
of drug resistance mutations associated with RT inhibitors. To investigate whether the
hotspot is associated with resistance mutations solely because these mutations repre-
sent the only variability in an otherwise conserved gene, we computed average pairwise
similarity between dataset sequences. However, similarity peaked just upstream of the
recombination hotspot, and the lowest similarity was observed in the 3’ of pol (data
not shown). Finally, the env analysis focused on the portion of env encoding gp120
(Fig. 4.3(c)) and revealed a concentrated recombination hotspot in the V3 loop.
4.4 Discussion
Our analysis of spatial variation in recombination rate combined the data from hun-
dreds of unique HIV-1 recombinants and revealed a distinctly non-uniform distribution
of recombination breakpoints along the genome. The overwhelmingly dominant hotspot
for recombination was in the reverse transcriptase gene, part of the pol open reading
frame. Other hot regions include p24 in the gag and essentially all of the env open
reading frame.
The spread of antiretroviral drug treatment around the world has placed the pol
gene under increasing selective pressure. Given reports that recombination contributes
to multi-drug resistance in vivo (Charpentier et al., 2006; Nora et al., 2007), the hotspot
in pol may result from intense selection of random recombinants that happen to combine
multiple drug resistance mutations in a single recombinant product. On the other hand,
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only 28% of the people needing treatment in low- to middle-income countries were esti-
mated to be receiving antiretroviral treatment by the end of 2006, which itself represents
a dramatic increase in the last three years (WHO, 2007). Since subtypes tend to co-
circulate mostly in low- to middle-income countries, it remains unclear if selection can
be a driving force in producing pol inter-subtype recombinants. Of the three previous
reports of a hotspot in pol (Jetzt et al., 2000; Magiorkinis et al., 2003; Thomson et al.,
2004), two (Magiorkinis et al., 2003; Thomson et al., 2004) are also based on in vivo
recombinants isolated at least three years ago. The third found 5’ pol to be the hottest
site for recombination in a single round infection assay (Jetzt et al., 2000), although the
viruses studied excluded the env gene. It is unlikely that widespread retroviral drug
selection can explain the hotspot in pol, but whether the pol sequence itself encodes for
high strand transfer potential can be assessed in the laboratory, and such experiments
are currently underway.
We have previously reported a recombination hotspot in the p24 region of gag based
on the analysis of 42 AG recombinants (Minin et al., 2007). Here, we analyzed 93 re-
combinants with all combinations of parents. Although different subtypes may vary in
the preferred strand transfer sites (Baird et al., 2006b), we detected a recombination
hotspot again in the p24 region of gag. In the previous analysis, no attempt was made
to screen for circulating recombinant forms (CRFs), but two CRFs are known have an
AG breakpoint in the gag gene (Kuiken et al., 2010). Here, by clustering recombinants
on their recombinant profile structure, we remove both recognized CRFs (Kuiken et al.,
2010) and those not yet reported. This discrepancy may explain why the hotspot is less
sharply located in our analysis. This portion of gag was not a hotspot in an in vitro
study of recombination, although a gag region just downstream was quite recombino-
genic (Moumen et al., 2001).
Recombination rates in the env gene were generally high (Fig. 4.1). Interestingly,
the 5’ end and extending into the accessory proteins vpr, tat, and vpu was hottest,
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along with the 3’ gp41 region. This pattern of recombination activity corroborates the
finding that the subtype of env, especially gp120, tends to be swapped in both CRFs
and unique recombinants (Kuiken et al., 2010; Renjifo et al., 1999; Takebe et al., 2003).
Our gp120-focused results revealed a hotspot in V3, which appeared as a mere blip in
the full genome. Because the 400 random sequences chosen in the full genome analysis
did not include all the 179 sequences of the local analysis, it is possible that the different
datasets have produced distinct results. However, the local analysis is unlikely to detect
breakpoints at the edges of env because there is insufficient upstream or downstream
information to infer a topological change (Suchard et al., 2003), so V3 is left as the sole
source of supported breakpoints in this region. Also, the specific location of the V3
hotspot could be an artifact of the extreme diversity of this region. Breakpoints may
actually locate in the conserved regions C2 or C3, which surround V3 and are confirmed
hotspots in experiment (Baird et al., 2006b). The poor alignment plus the effects of
the GMRF smoothing hyperprior could draw C2/C3 breakpoints into V3. In summary,
although we found evidence of recombination near the heavily reported C2 hotspot, it
was by no means the most active spot in vivo.
We briefly examined the correlation of sequence conservation and GC content with
the inferred full genome recombination rate estimates (Fig. 4.2). While correlations
were not strong and probably not significant in our datasets, we discuss here possible
reasons for the observed trends. Entropy, a measure of sequence diversity, was positively
correlated with recombination rate, in contrast to previous findings of a positive associ-
ation between in vivo recombination and pairwise subtype similarity (Magiorkinis et al.,
2003). Similarly, we observed a negative association between average pairwise subtype
similarity and recombination rate (data not shown). All the experimental evidence con-
tradicts the idea that recombination is promoted by sequence diversity (Baird et al.,
2006b; Gao et al., 2007). Instead, we hypothesize that the association results because
breakpoints are easier to detect and localize in regions of higher diversity. In other words,
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the results may reflect the fact that the underlying methodology (and any method) will
increasingly fail to detect recombination as sequence conservation increases (Posada and
Crandall, 2001). In contrast, we observed that GC content was negatively correlated
with recombination rate. This finding is odd considering that RT pausing occurs on
GC runs during minus strand synthesis (Klarmann et al., 1993). On the other hand,
AT excess may facilitate the dissociation and reassociation required for strand transfer,
independent of other predisposing features.
We have revealed that the in vivo pattern of recombination breakpoints along the
HIV-1 genome is highly non-uniform. We restricted our analysis to simple recombinants
involving at most two parental sequences, and we did not consider CRFs as parents,
which would allow detection of second generation recombinants (Toni et al., 2005). In-
clusion of more recombinants in the future will allow better resolution of spatial recom-
bination variation. While we tried to control for the presence of repeatedly sampled
recombinants by clustering on recombinant structure, we cannot guarantee that every
one of the 1, 701 breakpoints in our final dataset represents a unique recombination
event. However, if a breakpoint appears repeatedly in multiple contexts, then it is likely
selected. Ultimately, separation of mechanism and selection requires additional exper-
imentation and theoretical models. These results highlight more interesting regions to
target in such future study.
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Figure 4.2 Lag correlation of recombination and (a) entropy and (b) GC




























































Figure 4.3 Spatial recombination profile for (a) gag (b) pol (c) env
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CHAPTER 5. REVIEW II
This chapter reviews, in detail, the statistical theory and techniques used in the fol-
lowing chapters. The final section serves as a small introduction to the model presented
in the next chapter.
5.1 Markov Chain Monte Carlo : A Brief Primer
The goal of MCMC procedures is to sample from a target distribution. Instead
of sampling directly from the target, we sample from a Markov chain constructed to
have the target distribution as its equilibrium distribution. Given enough samples and
appropriate conditions on the chain, theory guarantees that the dependent samples will
be drawn from the target distribution (Tierney, 1994).
5.1.1 Metropolis-Hastings Algorithm
It is simplest to construct a reversible Markov chain, where the transition probabili-
ties p(·; ·) and equilibrium distribution pi(·) satisfy detail balance,
pi(θ)p(θ; θ∗) = pi(θ∗)p(θ∗; θ). (5.1)
Here, θ is a vector of model parameters. Applying principles of rejection sampling (Robert
and Casella, 2005), this transition kernel can be expressed as
p(θ; θ∗) = q(θ; θ∗)α(θ; θ∗), (5.2)
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for any arbitrary proposal distribution q(θ; θ∗), proposing θ∗ given current state θ, and an
acceptance probability α(θ; θ∗), insuring the stationary distribution pi(θ) is the desired
target distribution. Hastings (1970) shows acceptance probability









yields the desired equilibrium distribution pi(θ). To guarantee detail balance (5.1), any
transition from parameters θ to θ∗ with q(θ; θ∗) > 0 must be reversible, so q(θ∗; θ) > 0,
when the parameters are valid, i.e. pi(θ), pi(θ∗) > 0 (Tierney, 1994). The resulting
Metropolis-Hastings MCMC algorithm (Chib and Greenberg, 1995) samples θ1, θ2, . . .
from any target distribution pi(θ) in the following procedure.
1. Start with some initial value θ0 = θ
0.
2. Given the current iterate θt, repeat until convergence:
(a) Draw θ∗ ∼ q(θt; θ∗).
(b) Draw u ∼ Unif(0, 1).
(c) Compute α(θt; θ
∗).
(d) If α(θt; θ
∗) ≥ u, accept the proposal and set θt+1 = θ∗.
5.1.2 Gibbs Sampling
Gibbs Sampling (Resnik and Hardisty, 2009) uses full conditional distributions of a
multivariate parameter to sample from their joint posterior. Suppose that we wish to
generate samples from pi(θ) where now θ = (θ1, θ2 . . . θp). Without loss of generality,
let us consider a case where p = 2. The full conditionals of interest are pi(θ1|θ2) and
pi(θ2|θ1).
The Gibbs sampling algorithm prescribes the following procedure:




2. Given the current iterate θt, repeat until convergence:
(a) Draw θ∗1 ∼ pi(θ1|θ2 = θt2)
(b) Draw θ∗2 ∼ pi(θ2|θ1 = θ∗1)
Note that this scheme defines a reversible Markov chain that satisfies the detailed balance
condition and has equilibrium distribution pi(θ). Each iteration of the Gibbs sampler
may be viewed as p iterations of the Metropolis-Hastings sampler (Gelman et al., 2004).
However, the proposal distribution changes every iteration.
q(θ∗, | θt) =
p(θ
∗
1 | θt2,y) if θ∗2 = θt2
0 otherwise.
Consider the acceptance probability after a proposal for θ1 has been drawn. Here,
θ∗ = (θ∗1, θ
t
2) and the current iterate θ







q(θ∗ | θi) (5.4)
=
p(θ∗1, θ2 | y)




p(θ∗1, θ2 | y)p(θ1, θ2 | y)p(θ2 | y)
p(θ1, θ2 | y)p(θ∗1, θ2 | y)p(θ2 | y)
= 1
Thus every proposal is accepted.
The two algorithms described above may also be combined. One such method is the
Metropolis-within-Gibbs algorithm. Here, each parameter is individually updated fol-
lowing Gibbs sampling. However, in cases where the full conditionals are intractable, pro-
posal distributions may be used and individual Metropolis-Hastings acceptance/rejection
employed to obtain updated parameters.
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5.1.3 Multiple Changepoint Models and rjMCMC
Many times we are faced with a problem where the dimension of θ is unknown and
must be estimated. To be explicit, suppose that we have a set of responses y that arise
from one of a countable number of possible models M0,M1 . . .MK . Each model Mk, k =
0, . . . , K, has a parameter vector θk and the dimensionality of θk may vary with model
k. We are specifically concerned with multiple changepoint models, where an ordered
response vector y = (y1, . . . , yn) is hypothesized to be partitioned at k changepoints
s1, . . . , sk ∈ {2, . . . , n}. Between changepoints i and i+ 1, the data ysi , ysi+1, . . . , ysi+1−1
are iid realizations of some distribution f(y;µi), say a normal with known variance σ
2.
Model M0 corresponds to no changepoints, so all (y1, . . . , yn)
iid∼ N(µ0, σ2) and θ0 = µ0.
Model M1 has one changepoint, resulting in a parameter space with two means and a
change point location, θ1 = (µ0, µ1, s1). Similarly θ2 = (µ0, µ1, µ2, s1, s2) has another
two dimensions and so on. The goal is to infer the model index as well as the associated
parameters using the MCMC scheme and due to changing dimensions of the parameter
space, the rjMCMC scheme fits our needs very well.
5.1.3.1 Model
We describe a simple change point model. The purpose is to use simulation and a
simple model to illustrate the same approach we will use to model recombination-induced
change points in sequence data.
If parameters of model Mk are θk = (µ, s), our goal is to sample from the joint
posterior
pi(k,θk | y) ∝ L(y | k,θk)pi(θk | k)P (k). (5.5)
Conditional on the change points and means, the data are independent draws from
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normal distributions, so our likelihood is












where µ(i) = µj for all i belonging to partition j.
In the Bayesian context, we must propose a prior for all model parameters. We
assume the number of change points has a truncated Poisson prior
P (k) ∝ e
−λλk
k!
, 0 ≤ k < n,
where the constant of proportionality is the Poisson probability P (k < n). Conditional
on the number of change points, the locations and heights are independent. The locations
are order statistics of discrete draws without replacement on {2, . . . , n},
pi(s | k) = k!
(n− 1) · · · (n− k) .











5.1.3.2 Reversible Jump MCMC (rjMCMC)
In order to use MCMC techniques to make inference on problems with variable
dimension, Green (1995) suggested a reversible jump MCMC (rjMCMC) algorithm. As
in many MCMC procedures, rjMCMC alternates among different move types in order
to explore the parameter space. In our case, we define three possible moves types:
1. Stay (S): update parameters without changing the dimension,
2. Birth (B): addition of a change point, and
3. Death (D): deletion of a change point.
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The Birth and Death moves are trans-dimensional move types that require special pro-
posal distributions, with more involved calculation of proposal ratios, discussed in later
sections.
At each iteration of the MCMC algorithm, i.e. each transition, move S is attempted
with probability ek, B with probability bk, and D with probability dk, such that ek+bk+
dk = 1. These move probabilities depend only on the current number of changepoints
k. Since no more than n − 1 change points are allowed, we have bn−1 = 0. Otherwise,
we set
bk = c min
(
1,




dk = c min
(
1,




ek = 1− bk − dk,
where the constant c is chosen to be as large as possible while maintaining ek > 0.1 for







The key to trans-dimensional moves in rjMCMC is a bijective map f : (θk, ξ) ↔
(θk+p) between the lower dimensional parameter vector θk to the higher dimensional
parameter vector θk+p. To define the bijection, θk must be supplemented with vector ξ














where q(θ∗k+p;θk) is the proposal density for moving θk+p → θk, q(θk;θ∗k+p) is the pro-
posal density for moving θk → θk+p, and
∣∣∣∂θ∗k+p∂θk ∣∣∣ is the Jacobian for the bijection.
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We demonstrate below how to choose ξ and compute the acceptance ratios α(·; ·) for
our simple change point model.
Birth moves jump between parameter spaces θk and θk+1, specifically two states
θk = (µ0, . . . , µk+1, s1, . . . , sk) ∈ θk, and
θk+1 = (µ
∗








1, . . . , s
∗
j+1, . . . , s
∗
k+1) ∈ θk+1.
Thus, given k change points, a birth move increases the dimension from 2k+1 to 2k+3.
To match dimension, we must define two variables ξ = (s, u) to supplement parameter
vector θk. As usual, MCMC leaves a lot of choices up to the user. We choose to draw
s uniformly from the n− k− 1 locations that are not already changepoints to represent
the new change point s∗j+1. In addition u is a standard uniform random deviate used to
generate the new means (µ∗j , µ
∗















Uniform deviate u determines the variability in new means µ∗j and µ
∗
j+1 and µj is mapped
as the weighted average of µ∗j and µ
∗
j+1. With s = s
∗
j+1, all other parameter are mapped
one-to-one in the full bijection.
From the above description, the birth proposal is
q(θk;θ
∗
k+p) = bkq(s, u) =
bk
n− k − 1 ,
where we recognize that after choosing to attempt a birth move with probability bk and
generating the independent random variables s, u with probability 1
n−k−1 , the map is






where we choose to lose a change point with probability dk+1, select the change point
with uniform probability 1
k+1
, and progress deterministically from there. The important


























∣∣∣∣(s∗j+2 − s∗j+1)µ∗j + (s∗j+1 − s∗j)µ∗j+1(s∗j+2 − s∗j)(µ∗j + µ∗j+1)2
∣∣∣∣ .
(5.10)












× k + 1
n− k − 2
× λ
k + 1
× dk+1(n− k − 1)
bk(k + 1)
×
∣∣∣∣(s∗j+2 − s∗j+1)µ∗j + (s∗j+1 − s∗j)µ∗j+1(s∗j+2 − s∗j)(µ∗j + µ∗j+1)2
∣∣∣∣−1
}
where L(; ) denotes the likelihood and pi(µ) denotes the prior distribution on µ.
5.1.3.4 Death Move
The acceptance ratio in the death move is the inverse of the acceptance ratio for the

















∣∣∣∣(sj+2 − sj+1)µj + (sj+1 − sj)µj+1(sj+2 − sj)(µj + µj+1)2
∣∣∣∣}
5.1.3.5 Stay Move
If neither the birth nor death move is chosen, then we update each sj and µj in a
Metropolis-within-Gibbs step (Gilks et al., 1995).
 Define s0 = 0 and sk+1 = n, then for each sj ∈ s
– Propose a new s∗j+1 uniformly in the interval (sj−1, sj+1).
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 For each µj ∈ µ
– Propose a new µ∗j ∼ pi(µ).












5.2 Gaussian Markov Random Fields
Consider a random normal vector x = x1, x2 . . . xs which has, conditionally indepen-
dent components
xi⊥xj|x−ij (5.13)
i.e. xi and xj are independent conditional on all other components of x. Using a graph
G = (V,E) to represent the structure of this conditional independence, we have V as
the set of vertices, one for each xi and E as the set of edges, connecting any two vertices
that are dependent. x is now a GMRF with respect to G with mean µ and precision
matrix Q if and only if
f(x) ∼ N (µ,Q−1). (5.14)
It is easier to parametrize the GMRF in terms of its precision matrix since Qij = 0
when i⊥j and hence it is often a sparse matrix and easier to work with than a dense
covariance matrix Σ.
In some applications, the precision matrix may not be full-rank. This could be
due to the structure of G or more commonly due to linear constraints imposed on
the GMRF. GMRFs with sub-rank precision matrices are called Improper GMRFs.
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Of special interest are intrinsic GMRFs (IGMRF) that are improper GMRFs with a
precision matrix of rank n− 1 and Q1 = 0 meaning that
∑
j
Qij = 0 (5.15)
i.e. rows in the matrix sum to zero. Rue and Held (2005) illustrate the construction of an
IGMRF of first order on the line meaning that every node only has its two immediately
adjacent node, one on either side, in its neighborhood. The joint density of such a vector
x is given by









where ω is the multiplier for the precision matrix which has structure,










This prior, therefore penalizes large differences in recombination probabilities of ad-
jacent sites. The precision matrix Q as in Eq. 5.17. It follows that Pr(x|ω) ∼ N (0, Q−1)
and Q is non-full rank. Sun et al. (1999) showed that despite the improper prior, most
likelihood functions will still result in a proper posterior. The few that do not, notably,
include the binomial and Poisson distributions. In cases where our model requires use
of these distributions, we replace Q in Eq. 5.16 with a proper approximation such that
Pr(x|ω) ∼ N(0, Q˜−1) where Q˜ = Q+ I and  is a small positive constant and IN×N is
an identity matrix.
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Algorithm for sampling from x ∼ NC(b,Q)
1: Compute Cholesky Factorization, Q = LLT
2: Solve Lw = b
3: Solve LTµ = w
4: Sample z ∼ N (0, I)
5: Solve LTν = z
6: Compute x = µ+ ν
7: Return x
Table 5.1 Algorithm for simulation from a GMRF
5.2.1 Sampling from a GMRF
Canonical Parameterization of a GMRF For any normal random vector X,
















where Q = Σ−1 and b = Qµ and thus the mean of the original normal is µ = bQ−1
and variance is Q−1. Such parameterization may be extended to any exponential family
distribution.
Thus, a GMRF x with mean µ, precision matrix Q and canonical parameter b =
Q−1µ is expressed in canonical parameterization as :
x ∼ NC(b,Q)
In order to simulate from this GMRF, Rue and Held (2005) prescribe the following
algorithm
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5.3 Hierarchical GMRF Models
GMRFs find a wide variety of applications, the most useful of which involve hierar-
chical models with GMRF hyperpriors. Suppose that we observe some data y that are
dependant on a GMRF x. We assume that members of y are conditionally independent
given x. Let θ denote the hyperparameters that specify the GMRF. The hierarchical
setup now looks like this:
θ ∼ pi(θ) (5.19)
x ∼ pi(x | θ)
yi
iid∼ pi(yi | xi), i = 1, 2 . . . n
The posterior distribution is then
pi(x | θ,y) ∝ pi(θ)pi(x | θ)
n∏
i=1
pi(yi | xi) (5.20)
As a simple example, suppose that at the lower level or first stage of the hierarchical
model we observed data y = y1, y2 . . . yn that are counts of incidence of a disease in n
counties of a state. For this data we may assume a Poisson model with mean cex i.e.
yi ∼ P(ci exp(xi))
where c represents some known constant, the population in each county for example.
Let x represent the probability or incidence of the disease. The GMRF prior is placed
on x with precision ω and a Q matrix that reflects the actual spatial neighborhood of
each county (Besag et al., 1991; Rue and Held, 2005).
5.3.1 Inference Framework
Statistical inference of hierarchical models involving GMRF hyperpriors is done using
Markov Chain Monte Carlo algorithms. The choice of the algorithm used depends on
the lower level response model.
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5.3.1.1 Inference on Normal response models
Recall that in a hierarchical model setup, we wish to sample from the joint posterior
distribution (5.20). Let us consider models where the response can be modeled using
a Gaussian distribution i.e pi(yi|xi) ∼ N (xi, σ2i ). We can now express the combined
likelihood as a multivariate normal distribution
pi(y|x) ∼ MVN(x,M) (5.21)
where M denotes the precision matrix, which is this case is a N ×N matrix with entries

















∼ NC(b,Q+M ) where b = My
∼ NC(b,Q+ diag(c))
(5.22)
Expressed in this form, sampling proceeds using the algorithm outlined in Table 5.1.
Since we are drawing directly from a GMRF, this may be viewed as a Gibbs step.
5.3.1.2 Inference on Non-normal response models
Often we may be interested in modeling non-normal data through hierarchical GMRF
priors. In these cases, the likelihood is non-normal leading to a joint posterior that, unlike
the normal response model, does not retain its Gaussian properties. A Metropolis-
Hastings step is used to sample from such joint posteriors. To obtain a reasonable
proposal distribution, we build a GMRF approximation of the joint posterior by replacing
the likelihood with its second-order Taylor series expansion (Rue and Held, 2005).
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Second - order Taylor expansion Suppose that we want to approximate some
function f(x) using a quadratic Taylor expansion. Upon expansion around some point
x0, f(x) can be expressed as
f(x) ≈ f(x0) + f ′(x0)(x− x0) + 1
2
f ′′(x0)(x− x0)2









b = f ′(x0)− f ′′(x0)x0
c = −f ′′(x0)
(5.23)





(x− µ)TQ(x− µ) +
∑
i










(x− µ)T (Q+ diag(c))(x− µ) + (Qµ+ b)Tx
)
∼ NC(Qµ+ b,Q+ diag(c))
(5.24)
Sampling from this follows as before. However, we have an additional Metropolis-
Hastings acceptance step here to accept or reject the proposal drawn from the GMRF
approximation.
5.3.2 Blocking Strategies for Hierarchical GMRF Models
In a hierarchical setup with a GMRF hyperprior, precision ω is a smoothing param-
eter and may be fixed at an empirically determined value or sampled from the joint
posterior. In the later case, we may place a Γ(a, b) hyperprior on it. When ω is es-
timated, a block update strategy is employed (Rue and Held, 2005), i.e. the proposal
(ω∗,x∗) is accepted/rejected jointly. This is denoted as the one-block algorithm. The
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steps involved to are to sample
ω∗ ∼ q(ω∗ | ω) (5.25)
x∗ ∼ pi(x | θ∗,y)
Further, Rue and Held (2005) suggest the use of a symmetric proposal distribution for
ω stating that the ω chain thus generated is in fact sampling from the posterior marginal
pi(ω | y).
5.3.3 Extensions of the Hierarchical GMRF Model
Gaussian Markov Random Fields or Intrinsic CAR(1) priors have historically found
wide applications in spatial modeling. In a seminal paper, Besag et al. (1991) proposed
the application of standard Bayesian image restoration models to disease models. To
illustrate this model, consider the notation and example that they use. Suppose that we
want to model the risk of a disease over an area made of contiguous subunits or “zones”
(for example counties in a state, states in a country). Let ηi denote the log relative risk
in zone i ∈ (1, 2, . . . n) and yi be the corresponding observed number of cases.
We now assume that for a non-contagious and rare disease (cancer for example),
p(yi|xi) ∼ Poisson(ciexi) (5.26)
where ci is the expected number of cases in zone i assuming constant risk. In order to
jointly model the effect of fixed covariates and error terms, we express x as
x = α + u+ v
where α relates to some known/ fixed covariates akin to the intercept term, u to a
spatially structured error term and v to random noise.
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Priors u and v are assumed to be independent and v N (0, λ2). On u we put a













Note that expressing (5.28) as




σ(xi − ui − α)2
)
(5.29)
yields a conditional Gaussian distribution for the (xi | ui, τ) with mean (ui + α) and
precision τ .
5.3.3.1 Ecological regression model
The BYM model (Besag et al., 1991) can be extended further to include area level
covariates Zi by expressing x as:
xi = α + ui + vi + Ziβ (5.30)
where β is the coefficient of association and Zi pertains to the model matrix for obser-
vation i. A uniform prior is applied to β. This model is especially elegant in that it
enables one to not only smooth empirical data over “geographical” areas but also to find
links or associations of this data with covariates. Bernardinelli et al. (1997) extended the
ecological regression model to allow for covariates with errors, i.e. random covariates.
This is common is cases where Zi can not be observed directly. Suppose that we observe
some wi instead, the simplest approach is to use these to get estimates of Zi, i.e. Zˆi,
and use these for calculation. However, this approach relies heavily on wi being a good
approximation of Zi. When this is not the case this can yield underestimated β values
or overestimated precision measures. Additionally, if we have reason to believe that the
Zi themselves have a spatially correlated structure, then we can obtain better estimates
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overall by applying a spatial smoothing prior to Zi as well that is parameterized by its
own precision parameter ωZ .
5.4 Quantifying Association of Recombination Probabilities
with Covariates
Minin et al. (2007) presented a pioneering model that enables inference of population
level recombination probabilities through the use of a GMRF hyperprior that is able to
combine information of recombination events inferred from individual variants (referred
hereafter as the Minin model). In Chapter 4, I presented a large-scale application of
their model to full length genomic data in order to gain insights into occurrence of
recombination hotspots in the HIV genome. In Chapter 6 we present an extension of
this model that enables inference of coefficients of association of interesting covariates.
Further, we address certain data restrictions imposed by the Minin model. We present
these here briefly. The following chapter provides details.
Mapping to HXB2-relative positions: The Minin model requires the use of a
multiple sequence alignment of all sequences in a dataset. The need for such an alignment
precludes the analysis of large datasets. We propose mapping to HXB2-relative positions
instead creating a full multiple sequence alignment. While we lose some data pertaining
to gaps in HXB2, this is a reasonable trade-off for the ability to include a large number
of sequences in the analysis.
Constraints on recombination probabilities: The Minin model applies a con-
servative constraint to the sum of recombination probabilities restricting the expected
number of breakpoints in individual sequences to 0.693. However, application of this
constraint makes the assumption that all sequences used in the dataset are of nearly the
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same length. For full genome analyses of HIV, much valuable information can be gained
from partial genome sequences added to make up for insufficient full length data. Also,
as the incidence of recombinants in the global epidemic increases, producing more and
more complex recombinants, the assumption of less than 1 recombination breakpoints
may be too conservative. In our model, we remove the use of the constraint.
Ascertainment Bias: The choice of only recombinants in the dataset can lead to
erroneous interpretation of recombination hotspots due to sampling bias. Our model
corrects for this sampling bias by weighting probabilities used by individual sequences
by their length. The following chapter provides more details and some results.
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CHAPTER 6. DETECTING ASSOCIATION OF
RECOMBINATION HOTSPOTS WITH GENOMIC
FEATURES IN HIV-1
A paper to be submitted to Genetics
Misha L. Rajaram, Drena Dobbs, Susan Carpenter, Vladimir N. Minin and Karin S.
Dorman
Abstract
We present a Bayesian framework for inferring association of genomic features with
the spatial distribution of recombination probability from multiple putative recombi-
nants. Recombination confers on retroviruses, the ability to generate chimeric molecules
that may boost the replicative fitness of the virus. Many studies have shown that the
spatial preferences of recombination breakpoints across HIV recombinants is not uni-
form, leading to the presence of recombination hotspots. However, much ambiguity
exists around the molecular mechanism of recombination and the genomic features that
may be associated with recombination hotspots. We propose a hierarchical model that
allows for simultaneous inference of locations of recombination breakpoints in multiple
sequences, spatial variation of recombination rate in the genome and its association with
specified genomic covariates. At the lower level of the hierarchy, a phylogenetic recom-
bination detection model is applied to individual sequences to infer the presence and
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location of breakpoints via changepoint processes. At the upper level, recombination
probabilities are expressed as a linear function of covariates and spatially varying error
terms. We place a spatially smoothing Gaussian Markov Random Field (GMRF) prior
on the error term to combine information from the individual sequences. We applied the
model to a dataset of 527 simple recombinant sequences covering the HIV-1 genome. We
report a putative hotspot in the RT region of the pol gene and another in the nef gene.
We also found positively significant associations of recombination rates with propensity
to form secondary structures lending support to the hypothesis that pause sites trigger
recombination.
6.1 Introduction
The Human Immunodeficiency Virus (HIV) packages its genetic material in two pos-
itive sense RNA strands. The lack of an exonuclease proof reading mechanism, high
mismatch error rate in the transcription machinery and recombination lead to a high
genetic diversity of the virus that help it escape host immune mechanisms. Recombina-
tion occurs upon template switching by the reverse transcription machinery. When the
co-packaged RNA genomes belong to diverse genomic variants, recombination results in
new genetic variants called inter-subtype or inter-specific recombinants. In HIV-1 the
frequency of template switching can be anywhere between 7 to 30 times per genome
(Levy et al., 2004). Recombinants observed at least three times are characterized as
Circulating Recombinant Forms (CRFs); there were 43 known types as of 2009 (HIV-
Database, 2010). All other recombinants are called unique recombinant forms (URFs).
CRFs have triggered many local epidemics (Frange et al., 2008), and account for an
estimated 18% of the global epidemic (Buonaguro et al., 2007) and may gradually out-
compete the pure subtypes in the global infecting pool (Tovanabutra et al., 2004; Njai
et al., 2006; Wang et al., 2007). Subtypes and CRFs differ in virulence (Baeten et al.,
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2006), drug resistance (Spira et al., 2003; Madani et al., 2004) and sensitivity to detection
assays (Swanson et al., 2005; Colson et al., 2007).
Increasing experimental evidence suggests that strand transfer events do not occur
uniformly along the genome. There have been several hints of a hotspot in the 5’ portion
of the pol gene, both in experiment (Jetzt et al., 2000) and among in vivo recombinants
sampled from patients (Magiorkinis et al., 2003; Thomson et al., 2004; Galli. et al.,
2008). Another well studied hotspot is the conserved C2 region of env (Moumen et al.,
2001; Quinones-Mateu et al., 2002) although all conserved regions in env have relatively
high recombination rates (Baird et al., 2006a) and even variable regions are believed to
become hotspots with the right donor template (Baird et al., 2006b). Many inter-subtype
recombinants observed around the world display a recombinant pattern where the vari-
able loop V3, between C2 and C3 (Renjifo et al., 1999), or the complete gp120 portion
of env is swapped with another subtype (Takebe et al., 2003). Other regions implicated
as possible hotspots are 5’ gag (Dykes et al., 2004), the gag-pol boundary (Magiorki-
nis et al., 2003), the pol-vif boundary (Derebail et al., 2003), through vif into the 5’
env (Magiorkinis et al., 2003), a GC-rich region near the tat-rev splice site (Douglas
et al., 1996), and near nef (Magiorkinis et al., 2003). Indeed, very few genomic regions
are consistently “cold” but few studies have examined the entire genome at once and
experimental protocols and reagents vary widely. Additionally, little consensus exists on
what causes the replication machinery to fall off a template and on to another. Find-
ing association of recombination hotspots with genomic features may provide important
clues to dissecting the mechanism.
Most methods for detection of topology change points use phylogenetic inference (Hein,
1990). These methods exploit the fact that if recombination has occurred in a set of
aligned sequences then their phylogenetic relationships should differ on either side of a
breakpoint. Most popular approaches, therefore, use a sliding window technique to look
for support for alternative topologies (Grassly and Holmes, 1997; McGuire et al., 1997;
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Husmeier and McGuire, 2003). This method, however, suffers from a multiple testing
problem and low resolution for detecting breakpoints (Suchard et al., 2002). More recent
advances have been in the area of a Bayesian Hidden Markov Model (HMM), where the
underlying tree topologies are considered the hidden states while the actual observed
alignment is considered as the observed state. This method is more accurate than the
sliding window methods (Husmeier and McGuire, 2003). However, it is computationally
intensive and currently can only include up to four sequences in the alignment. Addi-
tionally, it assumes that all regions of the alignment are under similar selection pressures
which may be problematic (Dorman et al., 2002; Husmeier and McGuire, 2002).
Change-point models have been used to successfully model the spatial phylogenetic
variation along an alignment. A single multiple change point model (Suchard et al., 2003)
was extended to a dual multiple changepoint (DMCP) Model (Minin et al., 2005) that
successfully de-convolutes changepoints arising from recombination breakpoints from
other types of changepoints along an alignment. The DMCP achieves this by mod-
eling changes in nucleotide substitution pressures and tree topology as two indepen-
dent changepoint processes thus providing more accuracy to the recombination detec-
tion problem by decoupling the effect of nucleotide substitution from real tree topology
change.
Minin et al. (2007) introduced a Bayesian hierarchical model to combine breakpoint
information from many individual sequences in order to infer recombination hotspots at
a genome level. This model achieves such inference by assuming a genome level recombi-
nation probability that informs on the placement of breakpoints in individual sequences.
A spatially smoothing intrinsic Gaussian Markov Random Field (GMRF) prior is placed
on the vector of recombination probabilities. This prior defines the neighborhood of each
site, sites to its immediate left and right, enabling spatial smoothing by allowing the
sharing of information between neighbors. While pioneering in its application of the
GMRF prior to the inference of recombination hotspots in HIV, assumptions made in
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the above model preclude the use of a large number of sequences as also sequences of
disparate lengths.
In the present paper we describe a Bayesian hierarchical model that simultaneously
infers recombination hotspots and their association with genomic features. The lower
lever of the model infers topology change points in individual sequences using the DMCP
model from (Minin et al., 2005). The genome level counts for site-wise topology change-
points are then used to capture the recombination probability via a binomial likelihood
function. The upper level of the hierarchy makes inference on the recombination prob-
abilities as well as the regression coefficients measuring their association with input
covariates. A one-dimensional GMRF prior (Minin et al., 2007) is placed on the recom-
bination probabilities to enable smoothing of recombination probabilities. Further, in
order to take full advantage of all the publicly available HIV sequence data, we extended
the model so it is not only able to handle a large number of sequences but also sequences
of variable length. Our model also corrects, automatically, for any sampling bias that
the input dataset may introduce.
Section 2 provides an overview of the model as well as methodology adopted in
curation of the test dataset. Section 3 presents results of simulation runs with artificial
recombinant sequences of varying lengths and inclusion of different types of covariates.
The latter part of this section presents results from application of the model to a dataset
containing known HIV-1 recombinants and their association with genomic covariates. We
included GC content and sequence similarity as well as features associated with RNA
secondary structure formation. We find that the latter have a significantly positive
association with recombination probabilities, i.e. those that have been hypothesized to




6.2.1 Mapping Sequences to HXB2
Minin et al. (2007) map individual sequences to a population level vector by using
a multiple sequence alignment containing all sequences in the dataset along with their
putative parental sequences. However, this requirement becomes increasingly prohibitive
with larger datasets. We solve this problem by mapping individual sequences back to
HXB2 positions disallowing any gaps in the HXB2 sequence. While we lose information
about insertions relative to HXB2, the gaps are not long and this strategy does away
with the need for a multiple sequence alignment thus allowing for the inclusion of many
sequences in our dataset.
Let Y denote the data of K individual alignments, (Y1, Y2 . . . YK), each corresponding
to a multiple sequence alignment containing a putative recombinant and its parental
sequences. Note that gaps in the recombinant are removed from these alignments since
recombination breakpoints can not be placed at these gap sites. Individual sequences
may then be mapped to their corresponding HXB2-relative positions using a mapping
function:
fk : 1, 2....Lk → 1, 2...S
where Lk is the length of alignment Yk, S is the total length of the region of the HIV
genome covered by the dataset of K sequences and fk(i) is the HXB2 site corresponding
to site i in this alignment.
6.2.2 The Dual Multiple Changepoint Model (DMCP)
The lower level of the hierarchical model, infers recombination breakpoints in indi-
vidual alignments Yk via the dual multiple changepoint (DMCP) model (Minin et al.,
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k , following Hasegawa et al. (1985). The stationary distribution parameters
pikN , N ∈ {A,C,G, T} are fixed to the observed proportions in the input alignment.
We complete the specification of the phylogenetic model by specifying a bifurcating tree
topology τ
(l)
k that models the evolutionary relationship of the nucleotides in column Y
(l)
k .
An exponential prior with mean µ
(l)
k is placed on the branch lengths of the tree, to re-
duce the number of free parameters (Suchard et al., 2003; Minin et al., 2005). This
specification leads to a site-wise likelihood,
L(l)k = P (Y (l)k |τ (l)k , µ(l)k , κ(l)k ) (6.1)
A change point may occur when there is a change in the tree topology τk, a change in
the evolutionary parameters (µk,κk), or both. Let 1 = θ0 < θ1 < · · · < θMk+1 = Lk + 1
represent the locations of Mk unknown and distinct topology change points. All posi-
tions in the alignment between adjacent topology change points, i.e. l ∈ [θm−1, θm), 1 ≤
m ≤Mk +1 share a tree topology τ (m)k , and adjacent fragments have distinct topologies.
Let 1 = ρ0 < ρ1 < . . . < ρJk+1 = Lk + 1 be the locations of Jk distinct evolution-
ary changepoints that mark changes in evolutionary parameters. As before, all sites
of the alignment between two evolutionary changepoints share the same evolutionary
parameters.
The DMCP model is, therefore, completely defined by parameters
Φk = {Mk, Jk,θk, τk,ρk,µk,κk}.
Our interest is in the number and location of topology change points (Mk,θk). Hence,
we bundle the rest of the parameters as nuisance parameters in vector ψk. Priors on
nuisance parameters were set as described in Minin et al. (2007).
6.2.3 Prior on Location of Topology Changepoints
The upper level of the hierarchy combines information from the K recombinants
analyzed in the lower level of the hierarchy. We reconfigure the topology changepoints
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θk of recombinant k into a vector of indicator variables Bk = (Bk,1, Bk,2, . . . , Bk,Lk)
where Bk,l = 1 if l ∈ θk, 0 otherwise. Let ps ∈ p = (p1, p2 . . . pS) be the population-level
probability that site s is a topology change point. Then, the probability of the current
configuration of topology change points in alignment k is





)1−r, where r = {0, 1}. (6.2)
Conditional on the recombination probabilities ps, we assume that topology change
points are independent, so the joint likelihood of B is














Denoting all recombinants that did not have a gap character at site s as Cs =
∑K
k=1{s ∈
range(fk)} and the total number of times site s was inferred to be breakpoint as Rs =∑K
k=1Bk,s, (6.3) simplifies to
Pr(B1,B2, . . .BK |p) ∝
K∏
k=1
pRss (1− ps)Cs−Rs (6.4)
In order to infer recombination probabilities from the likelihood in (6.4), it is imperative
to define an informative prior structure on them. An efficient prior that is also biologi-
cally relevant is the Gaussian Markov Random Field (GMRF) prior (Minin et al., 2007).







and apply the GMRF prior to the recombination log-odds.









This prior penalizes large differences in recombination probabilities at adjacent sites.
We refer interested readers to Minin et al. (2007) for more details on the structure of
the precision matrix as well as adjustments made to ensure that the resultant posterior
is proper.
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6.2.4 Modeling Association of Genomic Features
In order to extend the current model to include covariates of interest, we express the
recombination log-odds ν as
νs = ηs +Xsβ (6.7)
where X denotes the model matrix, β, the set of regression coefficients and η is the
spatially varying component of ν. Note that ν is still a GMRF, now with mean Xβ
and dimension S + n where n is the dimension of β (Rue and Held, 2005).
We complete the Bayesian formulation of the model by specifying a non-informative
uniform prior on β and by fixing ω appropriately. In fact, ω can be viewed as a smoothing
parameter that can be adjusted to match the availability of data. Note that ω may be
inferred as well, in which case we place a Γ(ωa, ωb) prior on it where ωb is fixed at 0.02
and ωa at S − 1. For more details, we refer interested readers to Minin et al. (2007)
and Rue and Held (2005).
6.2.5 Inference via MCMC Simulation
The joint posterior distribution of all model parameters is




Pr(Yk | Φk)Pr(ψk)Pr(Rk | ν)× Pr(η | ω)Pr(β)Pr(ω).
In order to sample from (6.9), we employed MCMC simulation via the block update
scheme proposed by Rue and Held (2005) for sampling from distributions involving
GMRF hyperpriors. Model parameters were updated in three blocks. In the first block,
we updated parameters of individual alignments by sampling from their full conditionals.
Pr(Φ1,Φ2 . . .ΦK , | ν, ω, Y1, Y2 . . . YK) ∝
K∏
k=1
Pr(Yk | Φk)Pr(ψk)Pr(Rk | ν) (6.9)
Note that the Φk are conditionally independent, given ν and ω and simulation simply
involves cycling through all individual alignments. Minin et al. (2005) used an rjMCMC
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sampler to update parameters of individual alignments. In the current model, we re-
tain their sampling scheme with appropriate adjustments for the prior on locations of
topology changepoints.
At the upper level of the hierarchy, the full conditional is
Pr(η,β, ω | Y1, Y2 . . . YK ,Φ1,Φ2 . . .ΦK) ∝ Pr(R,C | ν)Pr(η | ω)Pr(β)Pr(ω) (6.10)
From (6.4) and (6.5), we may express Pr(R,C | ν) as










The second block consists of the spatial parameters η and ω that are updated jointly
following a strategy proposed by Rue and Held (2005). In the current model, however,
we fix ω, thereby reducing the parameter space of this block only to η. The third block
includes the β coefficients that are updated independent of the ν or ω updates.
From (6.10), the posterior marginal distribution of ν can be denoted as





Rsνs + Csln(1 + e
ν
s)). (6.12)
We use (6.12) to obtain full conditional for η as
Pr(η | β,R,C, ω) ∝ exp(−1
2
ηTQη + f(η;R,C)) (6.13)
where f(η;R,C) is the part of the likelihood pertinent to the full conditional of η.
Similarly, the full conditional for β can be denoted by f(β;R,C). Note that due to
the non-normal nature of the likelihood functions, these full conditionals are analyti-
cally intractable. To sample from them, we use the Metropolis-Hastings algorithm with
proposal distributions described below.
Applying the second order Taylor series expansion to f(η;R,C), we obtain a GMRF
approximation to (6.13) that may be used as a proposal distribution. Note that the
Taylor series expansion can be performed around the mode of (6.13) or the current state
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η. The proposal η∗ thus generated is accepted/rejected using the standard acceptance
ratio procedure of the Metropolis-Hastings algorithm (Hastings, 1970). In cases where
ω is also estimated, the proposals η∗ and ω∗ are jointly accepted/rejected. Arbitrary
normal proposal distributions were employed to update each of the members of β using
series of Metropolis-within-Gibbs steps.
6.2.6 Dataset
In order to study the association of recombination probability with sequence covari-
ates, we curated a dataset of 527 recombinants. To gain insight into features associated
with the mechanism itself, we curated the dataset in such a way that there were no
replicate representatives of a single recombination event. Starting with 2, 360 simple
recombinants, i.e those with only two parental genotypes, we grouped these into 544
clusters based on their profile structure. The profile structure of a recombinant refers
to the 5′ to 3′ listing of recombination breakpoints and the parental genotypes for ev-
ery segment created thereof. Rajaram et al. (2007) provides a detailed description of
the clustering algorithm. Because the HIV reference dataset used for parental genotype
does not have 5′ LTR sequences, we eliminated sequences that covered only this region
and truncated others that extend into the LTR region leading to a dataset of 527 recom-
binants. Lengths of the recombinants range between 400 and 8587 nucleotides covering
8924 nucleotides corresponding to the entire genome from the 3′ end of the 5′ LTR.
6.2.7 Correcting Ascertainment Bias
Ascertainment or sampling bias may result in erroneous inference of hotspots. In
the current context, this bias may arise when datasets are curated to contain only
recombinants and a portion of these only cover a short region of the genome. Repeated
inference of breakpoints from these recombinants may result in a posterior probability
profile that appears to have a hotspot in high coverage regions. To correct for the
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sampling bias, we use bias coefficients specific to each sequence. For recombinant k
covering region (lk, Lk) of the genome, we compute the bias corrected recombination
probabilities p∗fk(s) as
p∗fk(s) = Akpfk(s) (6.14)






To demonstrate the working of our model in detecting recombination hotspots and
their association with covariates, we designed a few simulation cases. We start with a
set of K simulated recombinants covering a region of 8121 sites corresponding to the
gag, pol and env genes of the HIV genome created using 80 non-recombinant full length
sequences each of the B and C genotypes. To test that the model handles sequences of
variable length, 25% randomly chosen sequences from this set were truncated so as to
cover only the gag gene and 25% others cover only the env gene. We set the “true”
recombination probability for these recombinants such that the region between sites
3500− 4500 had maximum probability of having a breakpoint, thus creating a hotspot
in the dataset. When a covariate was included, it was part of the “true” probability
profile used to create the simulated recombinants. Note that these probability profiles
are scaled so that the expected number of changepoints in a full length sequence is
0.693 so as to mimic simple recombinants (Minin et al., 2005). As a consequence, some
sequences were not recombinant and no ascertainment bias correction is needed. We
report 95% Bayesian credible intervals for the coefficients of regression of the covariates.
Coefficients whose credible interval includes 0 are said to have no association with the
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recombination probability.
We generated a dataset of 100 simulated recombinants as described above. The
probability profile used placed a hotspot in the 3500− 4500 region and had no included
covariates. The top left plot of Fig. 6.1 shows the simulated probabilities used to create
the recombinants. Solid dots on the plot mark the locations of breakpoints in the
dataset. As a control case, an unrelated covariate term was provided to the model during
inference. The top right plot in Fig. 6.1 shows the posterior inferred recombination
probabilities. It also indicates the 95% BCI for the coefficient of the unrelated coefficient,
with the middle number indicating the mean and the left and right flanking numbers
indicating the lower and upper bounds of the credible interval respectively. The use
of sequences of variable length does not affect the accurate inference of the hotspot.
Note also that BCI of the coefficient includes 0, i.e. no evidence of association with the
covariate, as is truly the case.
Next we tested a case where we included a normal random covariates in the recom-
bination probabilities used to create the test dataset. β was fixed at 1.0. The “true”
recombination probabilities still placed a hotspot in the region as above, however, the
profile of this density was not smooth as before. Fig. 6.1(c) shows the probability profile
with added covariate and the locations of breakpoints in the dataset of 100 simulated
sequences created from it. Fig. 6.1(d) shows the posterior inference of recombination
probabilities. The directionality of the β term was inferred correctly although its inferred
strength is diminished.
Finally, to test the scenario where the covariate itself may present with a continu-
ously varying structure, we used a probability profile as shown in Fig. 6.1(e). The first
“hotspot” region is created by the covariate, with β = 1.0 while the second hotspot in
the 3500− 4500 region is congruent with the ones in prior datasets and corresponds to
the spatial error term. Fig. 6.1(f) shows the inferred recombination probabilities. The
95% BCI for β was significant and positively associated. However the mean is much
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lower than the true value of β. We tested two more datasets, one with 250 sequences
and a third with 500 sequences and found that the mean of the inferred coefficient is
closer to the true value with more data.
To demonstrate the use of the ascertainment bias correction coefficients, we created
a simulated dataset of 100 recombinants. As before, 25 each of these covered the gag
and env regions and 50 were full length sequences. Here, we set the expected number
of breakpoints for each sequence, regardless of length, to 1 and these were uniformly
distributed along the genome resulting in no hotspots in the dataset. Fig. 6.3(a) shows
the posterior inference on this dataset without bias correction. Solid dots mark locations
of recombination breakpoints in the dataset. As predicted earlier, the recombination
profile shows a distinct pattern similar to the coverage pattern. Fig. 6.3(b) shows bias-
corrected posterior inference accurately reflecting the uniform distribution of breakpoints
in the dataset.
6.3.2 Analysis of Real Data
The model was used to analyze the dataset curated as described in section 6.2.6. Note
that since all the sequences were chosen to be recombinants, we applied the ascertainment
bias correction for this analysis. Figure 6.4 shows the posterior recombination probability
inferred from this dataset. The posterior mean probabilities are plotted (line) along
with the 95% credible interval (shading). Lack of parental sequence information in the
5’ LTR region caused us to exclude this region. The x-axis is numbered relative to
HXB2 positions. A hotspot occurs in the 5′ end of the pol gene coding for the reverse
transcriptase enzyme. Another hotspot occurs in the gag gene. The 3′ end of the pol
gene coding for protease is particularly cold. The env gene tends to have moderately
high recombination rate throughout. A peak is observed in the region overlapped by nef
and the 3′ LTR.
The next few sections present results of associations with various covariates. Table 6.1
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provides a summary of the mean and 95% BCI for the association coefficients. It should
be noted that all covariates were normalized before inference and as such the magnitude
of the coefficients obtained are directly comparable to each other.
Association with known recombination hotspots: Many previous studies
(Moumen et al., 2001; Dykes et al., 2004; Balakrishnan et al., 2003; Zhuang et al.,
2002; Baird et al., 2006b) have, through in vitro systems or single cell infection assays,
identified recombination hotspots along the HIV-1 genome. To test how these translate
to in vivo sequences where they face selection pressure, we included as covariate an
indicator variable that had a value 1 for any nucleotide that was part of the hotspots
identified by Moumen et al. (2001); Zhuang et al. (2002); Dykes et al. (2004) and Baird
et al. (2006b), and 0 otherwise. We found no significant association with these hotspots.
GC content and Sequence Similarity: Rajaram et al. (2007) examined the
correlation between GC content and sequence similarity with posterior recombination
probabilities. Here we included these as covariates in the model. GC content was
summarized using sliding windows of sizes 20, 50 and 100 bp. The GC content at site s
is the proportion of G and C nucleotides within a window of size n centered at site s.






where ρ(s,i) corresponds to the proportion of appearance of nucleotide i at site s in the
entire dataset. Further Magiorkinis et al. (2003) reported association with upstream
sequence similarity and frequency of recombination. To summarize this, we also con-
sidered entropy covariates in sliding windows of size 10, 20 and 50 bp. In this case
the entropy at site s was computed as the average positional entropy of the nucleotides
occurring in the window starting at that site.
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The association of GC content is positive and increases with increasing window
size. Site-wise entropy has a negative association with recombination probability while
window-wise entropy has a positive association. The strength of window-wise entropy
associations also increases with larger windows.
Deletions: The jumping reverse transcription complex, could introduce insertions
and deletions in the resultant recombinant. While our use of HXB2 mapping of indi-
vidual sequences prevents the analysis of insertions, we may use deletion counts to test
their association with recombination probabilities. The deletion count at site s is the
length of the gap region that follows it. The mean of the coefficient was inferred very
close to 0 with its 95% BCI including 0.
Thermodynamic stability of RNA/DNA hybrid: Sugimoto et al. (1995) pro-
vided parameters for the nearest neighbor computations to predict the thermodynamic
stability of a RNA/DNA hybrid. The covariate at site s was the total free energy,
∆G37 deg, of the 9-mer centered at site s computed using the nearest neighbor method.
The association of this covariate with recombination probability was inferred to be sig-
nificant and negative.
Covariates associated with RNA Secondary structure: Next we examined
association of some covariates that indicate formation of secondary structures by the
genome RNA. Many studies (Galetto et al., 2006; Moumen et al., 2003; Roda et al.,
2002b) have indicated association of secondary structure with recombination and hy-
pothesize that a loop may act as a pause site for the reverse transcription machinery,
encouraging it to fall off the template genome. Shen et al. (2009) showed that G-rich
stretches along the HIV genome are prone to formation of tetraloops and associated
with recombination. To include the presence of G-rich regions as a covariate we adopted
the following coding system. All nucleotides other than G were coded 0. Guanosine
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nucleotides were coded in increasing order, i.e. the first in a stretch of Gs was coded 1,
the next 2 and so on until the stretch was interrupted with a non-G nucleotide, resetting
the counter to 0. The coefficient for this covariate is positive and significant.
Watts et al. (2009) recently elucidated the secondary structure of the HIV genome
using the high-throughput selective 29-hydroxyl acylation analysed by primer extension
(SHAPE) (Wilkinson et al., 2006; Deigan et al., 2009) method. SHAPE reactivity mea-
sures the propensity of a nucleotide to be acetylated. It, therefore, provides very clear
information of whether a nucleotide is involved in a secondary structure or not. High
SHAPE reactivities indicate unstructured nucleotides or absence of secondary struc-
tures. They also use a method suggested by (Pedersen et al., 2004) to compute pairing
probabilities at each nucleotide. This algorithm does not involve chemical or thermo-
dynamic computations and has opposite directionality to the SHAPE reactivities, i.e.
high pairing probability indicates higher propensity for the nucleotide to be part of a
secondary structure. We provided the SHAPE reactivity and pairing probabilities as
covariates and found that the resultant coefficients were significant. SHAPE reactiv-
ity was negatively associated with recombination probability while pairing probabilities
were positively associated.
6.3.3 MCMC Convergence Diagnostics
At the lower level, individual scaled regeneration quantile (SRQ) plots for the total
number of inferred breakpoints Mk were examined to assess convergence. For the DMCP
model, the time evolution of Mk is a vital indicator of mixing in the reversible jump
MCMC sampler. Mykland et al. (1995) suggest that for renewal process such as the
MCMC sampler of the DMCP model, plotting its regeneration times can be used to
assess convergence. Mk has a discrete state space and we mark the state denoting the
posterior median number of breakpoints as the state of interest m. For an MCMC run
of fixed length, ti, i = 1, 2 . . . n are the time steps at which state m was visited where
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n is the random total number of visits to state m. A plot of ti/tn vs. i/n close to the
diagonal corresponding to the y = x line indicates convergence. Fig. 6.5 shows the SRQ
plots for all 527 individual sequences in our real dataset with all lines lying very close
to the diagonal.
We employ the Geweke statistic (Geweke, 1992) to test convergence at the upper
level. The first 10% and last 50% samples were used for this test. Geweke suggests that
treating the samples as a time series, the Z-statistic for the difference of the means thus
computed is asymptotically normal. A Z-test was performed for mean ν at each position
and mean β for the two samples. No difference was found significant thus indicating
convergence.
6.4 Discussion
We presented a hierarchical model that can assess, for a set of putative recombinants,
presence of recombination hotspots and their association with covariates. Extending the
model presented by Minin et al. (2007), we are now able to deal with large datasets
that may also include sequences of varying lengths. As the simulation results indicate,
providing more information in terms of a larger number of sequences can greatly help in
achieving better resolution of the inference. Further, the model also handles bias arising
from sampling a subset of sequences. This bias becomes especially acute when sequences
with varying lengths are allowed. In trying to understand the molecular mechanism of
recombination, care must be taken to ensure that recombinants chosen do not represent
replicates of the same recombination event. Covariate associations found in datasets
with replicates while informative on replicative fitness of a recombinant, do not provide
insights into the mechanism itself. Abundance of a particular recombinant in the dataset
will result in heightened recombination probabilities in areas near its breakpoints leading
to spurious hotspot inference. The bias correction included in the current model handles
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this by weighting the recombination probabilities at the lower level by the length of the
individual sequence.
We used a carefully curated dataset to find associations with sequence features. Anal-
ysis of this dataset reveals that considerable spatial variation in recombination probabil-
ity along the HIV genome. Galli. et al. (2008) hypothesized the presence of a recombi-
nation hotspot through a computational study that compared frequency of breakpoint
occurrence to frequency of occurrence of hairpin loops in the pol gene. The advent of
drug therapy and the subsequent drug resistance mutations that have accumulated in
regions that are drug targets, such as RT could be a cause for this hotspot (Charpentier
et al., 2006; Nora et al., 2007). However, drug therapy itself is not very prevalent in
poorer sections of the world (WHO, 2007) and may not fully explain the hotspot. A
hotspot in the gag gene was reported in an experimental study (Shen et al., 2009). Minin
et al. (2007) also reported a putative hotspot in the gag gene from the application of
the hierarchical GMRF model to a set of A/G recombinants. The peaks in the env gene
occurred at the edges of the gp120 coding region. The surface glycoprotein, gp120, is the
first line of attack for the virus and switching it out with that of a different genotype may
confer evolutionary advantage. Indeed, in some A/E recombinants from Thailand, the
gp120 coding region is from subtype E while the rest of the virus is subtype A1 (Sabino
et al., 1994). This is also a highly successful recombinant and one of the major infecting
types of the region. Evidence of recombination in the nef gene was earlier reported in
in vitro studies of SIV. More recently, inter-subtype env-nef recombinants have been
reported in India (Bhanja et al., 2007).
6.4.1 Quantifying Associations with Genomic Features
We performed a series of experiments with simulations to test our model for most
plausible scenarios. β was underestimated when a random covariate is included. This
may be attributed to the spatial term accounting for some of the random noise added by
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the covariate. Estimates for covariates of this nature are thus bound to be conservative.
Further, we found that adding more sequences to the dataset results in more lucid
posterior inferences. An advantage our model has over previous models is its ability to
test a large number of sequences simultaneously.
Much debate exists on the molecular mechanism of recombination, specifically the
triggers that prompt the replication machinery to fall off a donor template, the “sig-
nals” that help it anneal to a receptor template and the many interactions involved in
between. Galetto and Negroni (2005) provide an extensive review of evidence to sup-
port the copy choice model for recombination (Hu and Temin, 1990). Magiorkinis et al.
(2003), through a combination of in vitro and computational studies, provide evidence
that they interpret as support for strand displacement-assimilation model. Many other
in vitro studies have found association of recombination with RNA secondary struc-
tures (Galetto and Negroni, 2005; Moumen et al., 2003; Roda et al., 2002b), GC rich
regions (Klarmann et al., 1993) etcetera. However, how these forces act in vivo, if at
all, has been difficult to measure. This model provides a paradigm for simultaneous
inference of recombination hotspots and coefficients of association.
Recent studies have demonstrated the presence of recombination hotspot along the
HIV-1 genome (Zhuang et al., 2002; Balakrishnan et al., 2003; Dykes et al., 2004; Galetto
et al., 2006; Moumen et al., 2001). However, these studies were performed using recon-
stituted in vitro systems or using single infection assays in vivo. It must be noted that
sequence data available from patients constitutes viruses that have undergone selection
pressure and hence these may not exhibit the hotspots found in the studies above. In-
clusion of a covariate that measures association of recombination hotspots identified
by (Moumen et al., 2001; Zhuang et al., 2002; Dykes et al., 2004; Baird et al., 2006b)
results in a coefficient with no effect. This suggests that selection plays a role in the
evolution of the virus within infected individuals.
GC content is one of the simplest features summarizing the genome. In the current
102
study we find a positive and significant association of recombination probability with
GC content and it is found to increase with larger windows. However, this association
may possibly reflect the varying GC content across the genome itself. Klarmann et al.
(1993) reported that the transcription machinery pauses at GC rich stretches and this
correlation may be indicative of the association of pauses and recombination.
Entropy is also found to have significant association with recombination probability.
Per-site entropy had a negative association, supporting the theory that some amount of
homology is necessary at recombinogenic regions. However, we find that window-wise
entropy had the opposite effect. While it is possible that variability may be associated
with high recombination rates, a more plausible explanation is that these reflect the
mechanism of inference of breakpoints rather than a true association. The lower level
DMCP model, by virtue of being a phylogenetic recombination detection model requires
some amount of variation to be able to place recombination breakpoints in a region.
The strength of the RNA/DNA hybrid may contribute towards keeping the transcrip-
tion machinery on the donor template, thus preventing recombination. The significant
negative association to this covariate supports this hypothesis. This effect is orthogonal
to the effect of secondary structures. Secondary structures have been hypothesized to
cause the transcription machinery to pause or sometimes prevent it from moving fur-
ther (Dykes et al., 2004; Lanciault and Champoux, 2006). Such pause sites may provide
an impetus to recombination events (Roda et al., 2002a, 2003; Zhuang et al., 2002). We
summarized the propensity for secondary structure formation using three covariates.
Shen et al. (2009) hypothesized that the presence of guanosine rich runs may promote
the formation of secondary tetra-guanosine loops. A significant positive association of
this covariate with recombination probability was observed. Watts et al. (2009) provide
details of SHAPE reactivities and pairing probabilities of the HIV-1 genome. Regions
with high SHAPE reactivities are considered to be unstructured loops while those with
medium- to low-random reactivities may be members of a loop. Similarly, pairing proba-
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bilities measure the propensity of a nucleotide to be part of a secondary structure. Lower
pairing probabilities indicate unstructured regions. Significant negative and positive as-
sociations were observed with SHAPE reactivity and pairing probabilities respectively.
The factors promoting recombination in vivo are largely unknown (Negroni and Buc,
2001). This model provides a unified framework to infer these associations. The covari-
ates in turn augment the recombination hotspot prediction by infusing more data into
the model. Overall, our model is superior to previous efforts that use phylogenetic
recombination detection to infer spatial variation of recombination probability and its
association with sequence features (Magiorkinis et al., 2003; Zhang et al., 2005). Using
the hierarchical setup it is able to integrate over all recombination breakpoints inferred
at the lower level.
The model may also be used to comment on epidemiological impact of recombina-
tion. Using datasets representative of specific time periods in the evolution of the virus,
comparative studies can be carried out to examine if and how the spatial variation of
recombination rates differs between the two time periods. Covariates such as presence
of drug resistance mutations may be included to test if they share a significant associ-
ation with the change in recombination probability profile. Finally, the model may be
extended to include covariates at the level of the individual sequence. This extension
will enable testing of some very interesting temporal and geographical hypotheses such
as, how the spatial recombination profile has changed over time, how recombinants from
one geographic region compare with those from another in propensity to recombine and
placement of hotspots, how genotypes differ in these aspects and so on.
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Figure 6.1 (a) Recombination probability profile with no included covari-
ate (b) Posterior inference for dataset generated in (a) analyzed
with an unrelated covariate. (c) Recombination probability pro-
file with including a randomly varying covariate (d) Posterior
inference for dataset generated using profile in (c).
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Figure 6.2 (a) Recombination probability profile with spatially structured
covariate (b-d) Posterior inference for dataset with 100,250 and
500 simulated recombinants respectively, generated using profile
in (a).
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Figure 6.3 Results from simulation dataset to test correction of ascertain-
ment bias (a) Posterior inference before bias correction. Solid
dots indicate locations of breakpoints in the dataset. (b) Poste-
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Figure 6.4 Posterior recombination probability for full genome HIV-1
dataset after bias correction
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Figure 6.5 MCMC convergence diagnostics: SRQ plots for individual
DMCP samplers
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Covariate Mean coefficient 95% BCI
in vitro hotspots 0.1261 (−0.0131, 0.3587)
GC content (20) 0.2760 (0.1817, 0.3805)
GC content (50) 0.3185 (0.1932, 0.4404)
GC content (100) 0.3489 (0.2120, 0.4595)
Entropy (sitewise) −2.5561 (−2.9151,−1.9041)
Entropy (10) 1.8577 (1.4276, 2.3050)
Entropy (20) 1.9109 (1.505, 2.301)
Entropy (50) 2.4460 (1.9691, 2.9172)
Deletions 0.0081 (−0.0281, 0.0162)
Thermal Stability −0.2014 (−0.3729,−0.0590)
G-rich stretches 0.7361 (0.6269, 0.8428)
SHAPE reactivity −2.3934 (−2.6328,−2.1549)
Pairing probability 2.3896 (2.0642, 2.6857)
Table 6.1 β coefficients inferred from full length HIV-1 genome analysis
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CHAPTER 7. ALTERNATE HIERARCHICAL GMRF
PRIOR SPECIFICATION IN BINOMIAL RESPONSE
MODELS
7.1 Introduction
In this chapter we motivate the use of the alternatives to the model described in
earlier chapters. Briefly, in the hierarchical setup described hitherto, the upper level
placed a GMRF prior on the population-level recombination probabilities p. The lower
level of the hierarchy inferred recombination breakpoints in individual sequences and
these were communicated to the upper level through count data. This setup resulted in
a binomial likelihood,
pi(R | p) ∝
S∏
s=1
pRss (1− ps)Cs−Rs (7.1)
where Rs is the number of time site s was a inferred to be a breakpoint at the lower level,
C tracks the total number of times site s was represented in the dataset and S is the
total length of the genome covered by the dataset. Placing a GMRF prior on the logit











where fs refers to the likelihood function at site s. With a binomial likelihood, Rue
and Held (2005) suggest approximating the likelihood using a second-order Taylor se-
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ries expansion and using the resultant GMRF approximation density as the proposal
distribution in the Metropolis algorithm.
In the model discussed in this section, we apply an arcsin transformation on the count
data such that the site-wise likelihood is asymptotically normal instead of binomial.
This in turn results in the density (7.2) remaining a GMRF enabling direct sampling in
a single Gibbs step as described in Chapter 5. This setup increases the speed of inference
twofold. However, the proposed transformation method results in range restrictions on
the inference that may limit its use to large datasets. We discuss the model setup , its
merits and demerits in detail in the following sections.
7.2 Methods
We propose a toy example to illustrate the current model. At each site of the
“genome” covered by the dataset the input data is in the form of normal random variates
instead of sequence data. Each input vector was generated from a series of normal
distributions thus creating changepoints in it. These changepoints are detected by the
lower level of the hierarchical model. The upper level models the probability of a site to
be a changepoint.
Suppose that we start with a dataset comprised of K individual data vectors of
lengths L1, L2 . . . LK respectively. Each data vector, yk = (yk,1, yk,2 . . . yk,Lk) is a set of
Lk observations that are piecewise i.i.d.. Further, each vector has J changepoints such
that observations in partition j ∈ (1, 2, . . . J + 1) are random variables from a N (µj, σ2j )
distribution.
7.2.1 Multiple Changepoint Model
At the lower level of the hierarchy our goal is to infer the number and location of
the changepoints in individual data vectors. Denoting the model under J changepoints
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as MJ , the corresponding parameters are θJ = (µJ ,σ
2
J) where µJ = {µ1, µ2 . . . µJ+1}
denotes the means of normal variates in the J+1 partitions and σ2J denotes the respective
variances. The goal is to sample from the joint posterior
pi(J,θJ | yk) ∝ L(yk | J,θJ)pi(θJ | J)P (J). (7.3)
Conditional on the change points and means, the data are independent draws from
normal distributions, so the likelihood is












where µ(s) = µj for all s belonging to partition j.
7.2.1.1 Prior Specification
We assume the number of change points has a truncated Poisson prior
P (J) ∝ e
−λλJ
J !
, 0 ≤ J ≤ Lk,
where the constant of proportionality is the Poisson probability P (k < n). Conditional
on J , the locations of change points and means for the partitions created thereof, are
independent. The locations are order statistics of discrete draws without replacement
on {2, . . . , n},
pi(s | J) = J !
(n− 1) · · · (Lk − J) .











where µµ is the mean and σ
2
µ is the variance of the hyper-distribution. These are fixed
at arbitrary values. The variance σ2j for data in each partition is also fixed.
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7.2.2 GMRF Prior on Changepoint Probabilities
At the upper level of the hierarchy, we analyze the entire dataset of K data vectors.
We summarize the information from the lower level inference in the form of two vectorsR
and C. Rs is the count of the number of times site s was inferred to be a changepoint by
the lower level analysis of the K data vectors. Cs is the number of trials/opportunities
site s had to be a changepoint. In other words, it is the number of times site s is
represented in the dataset.
7.2.2.1 Arcsin data transformation
So far, the current model is identical in setup to the model described in previous
chapters. However, instead of using the data directly in the form of counts R and C,we






When transformed thus, the distribution of Z is N (arcsin(√ps), 1/4Cs) asymptotically.
Applying this transformation, the likelihood may now be expressed as,
pi(Zs | ps) ∝ N (νs, 1/4Cs) (7.5)
Implying ,
pi(Z | p) ∝ N (ν, I/4C)
where νs = arcsin(
√
ps). A simple GMRF with precision matrix as described in previous
chapters is placed on the vector ν with precision ω.
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7.2.3 Inference via MCMC Simulation
We sample from the joint posterior of all model parameters, (7.6), using MCMC
simulation.
Pr(θ1,θ2 . . .θK ,ν, ω | y1,y2 . . .yK) ∝
K∏
k=1
Pr(yk | θk)Pr(θk)×Pr(Z | ν)Pr(ν | ω)Pr(ω).
(7.6)
As before, we use a Metropolis-within-Gibbs scheme to update the model parameters in
two major blocks. In the first block we simulate from the full conditional distribution
of the lower level parameters
Pr(θ1,θ2 . . .θK | ν, ω,y1,y2 . . .yK) ∝
K∏
k=1
Pr(θk|ν, yk) = Pr(yk | θk)Pr(Rk|ν)Pr(ψk)
(7.7)
The second block of parameters consists of the ν vector and the precision ω.
Pr(ν, ω) ∝ Pr(Z|ν)Pr(ν | ω)Pr(ω) (7.8)
Unlike the scheme described in previous chapters, sampling from (7.8) may be achieved
in a single Gibbs step when ω is fixed. The distribution we wish to sample from is of
the general form as given in (7.2). Since the likelihood is normal, this remains a GMRF
that we may directly sample from with methods described by Rue and Held (2005).
When ω is not fixed it may be updated as described in Minin et al. (2007). However,
the acceptance ratio should pertain only to ω in this case.
7.3 Results
7.3.1 Simulated Dataset
To test the working of current model we generated a simulated dataset of K = 100
data vectors each of length L1 = L2 = . . . = Lk = 100 sites. For each dataset, the
number of changepoints J was fixed at four with locations fixed at positions 21, 41, 61
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and 81. Normal random variates within each of the five partitions created thereof, were
generated from N (µj, 1) distributions. Each µj, in turn, was generated from a N (5, 1)
distribution. Fig. 7.1 provides a schematic view of the simulation of a data vector.
We generated 11000 samples from the joint posterior, discarding the first 1000 as
burn-in and sub-sampling the rest at every 10 samples to generate 1000 posterior sam-
ples. At the lower level, the sampler identified the 4 changepoints in all 100 data vectors
accurately. Fig. 7.2 shows the posterior mean of the GMRF µ with ω fixed at a value
of 10.0.
MCMC convergence diagnostics were performed at the lower level, at the number
of changepoints and at the upper level on the inferred vector ν as described in the
preceding chapter and the sampler was found to have converged at both levels (result
not shown).
7.4 Discussion
We presented an alternative to the binomial likelihood representation of count data
in hierarchical GMRF models. The arcsin transformation is advantageous in the case
where a GMRF prior is applied to the upper level parameters since it specifies a normal
likelihood. For normal response models, a sample may be drawn directly from the
full conditional as described in (7.2) that remains a GMRF. When ω is fixed, the Gibbs
algorithm may be employed to generate new MCMC samples. When ω is to be estimated,
we use a Metropolis-within-Gibbs approach, updating ν in a Gibbs step as described
above followed by a Metropolis step for ω.
Finding the GMRF approximation of a non-normal likelihood is computationally
intensive and relates directly to the length S of the region being analyzed. Doing away
with this step increases the speed of inference twofold. The previous chapter discusses
the advantages to adding a large number of sequences to the input dataset. Indeed
116
the model described in the previous chapter is also able to handle a large number of
sequences. However, with the increase in speed afforded by the current model, even
larger datasets may be analyzed in a reasonable length of time.
The arcsin transformation stabilizes the variance of the data. However, it restricts
the range of the parameter to (−pi/2, pi/2) which is further restricted to (0, pi/2) when
dealing with probabilities. In a simple input data case such as the one presented in this
example, this is not a problem. However, as the real probability goes closer to zero, as
may be the case in sequence data, especially in regions that are conserved “cold spots”
for recombination, the inference produces negative values that are outside the allowable
range (data not shown).
Several solutions are currently being explored for this problem, including fixing a
mean level and increasing the number of sequences. Once this problem has been ad-
dressed, the current model will be powerful in that it combines all the advantages of
previous models with faster inference.
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1 ~ N(5,1) 2 ~ N(5,1) 3 ~ N(5,1) 4 ~ N(5,1) 5 ~ N(5,1)
Changepoints
… … … Y20Y1 Y2 Y3 … … …
Figure 7.1 Schematic representation of data generation
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Figure 7.2 Posterior mean of µ in the hierarchical changepoint model
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CHAPTER 8. GENERAL CONCLUSIONS AND FUTURE
WORK
The genetic diversity of HIV has long been a challenge in efforts of developing pre-
ventive therapies against the pathogen. Adding to the diversity are chimeric molecules
produced by recombination. The genetic variants thus formed, along with the existing
non-recombinant forms results in a wide range of host-pathogen interactions. Efficient
clinical management of the disease necessitates, as a first step, the ability to identify the
infecting genotype effectively. Further, a stepping stone towards effective therapeutic
intervention of infection and subsequent progression of the disease is, veritably, better
understanding of the mechanism of recombination. In this thesis, I described a rapid
HIV genotyper based on supervised learning algorithms, a hierarchical model for simul-
taneous inference of spatial variation of recombination probabilities and covariates of
interest and the application of this model to curated HIV datasets to gain insights into
the mechanism of recombination.
8.1 HIV Genotyping
Application of machine learning algorithms to the problem of genotyping HIV se-
quences proved to be very successful. Compared to current genotyping tools, it is able
to better classify complex recombinants. The success of the HIV genotyper can be aug-
mented by providing many pre-made classifiers. Towards this, the short-term goal is
to make the web tool a community-based effort, encouraging users to train classifiers
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specific to sequences of their interest and share these with the community. Further,
this genotyping method could find valuable application in the classification of bacterial
sequences as well as classification of other retroviral sequences. In fact, when provided
with a relevant training set, the genotyper may be able to classify retroviral sequences
efficiently with the current feature sets. Bacterial sequences, on the other hand, may
require more calibration in terms of optimized feature sets as well as the most suited
supervised learning algorithm.
8.2 Hierarchical GMRF Model
We found, through analyses presented in this thesis, evidence supporting the hypoth-
esis that propensity to secondary structures is directly correlated with high recombina-
tion rates. The framework provided by this model can be exploited to further dissect
the molecular mechanism of recombination. In the future, I plan to extend the current
model to include covariates at the level of the individual sequence. Such analyses can
provide valuable insights into evolution of the virus. Covariates associated with recom-
bination probabilities in such a set up will provide evidence for selection pressures acting
on various regions of the virus. Further, epidemiological evidence can also be gathered
through association of recombination rates with geographic location, time of infection
and the interaction of these covariates with genotypes.
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